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Abstract
Amygdalin is the major cyanogenic glycoside present in apricot kernels and is degraded to cyanide
by chewing or grinding. Cyanide is of high acute toxicity in humans. The lethal dose is reported to be
0.5–3.5 mg/kg body weight (bw). An acute reference dose (ARfD) of 20 lg/kg bw was derived from
an exposure of 0.105 mg/kg bw associated with a non-toxic blood cyanide level of 20 micro mol (lM),
and applying an uncertainty factor of 1.5 to account for toxicokinetic and of 3.16 to account for
toxicodynamic inter-individual differences. In the absence of consumption data and thus using highest
intakes of kernels promoted (10 and 60 kernels/day for the general population and cancer patients,
respectively), exposures exceeded the ARfD 17–413 and 3–71 times in toddlers and adults,
respectively. The estimated maximum quantity of apricot kernels (or raw apricot material) that can be
consumed without exceeding the ARfD is 0.06 and 0.37 g in toddlers and adults, respectively. Thus
the ARfD would be exceeded already by consumption of one small kernel in toddlers, while adults
could consume three small kernels. However, consumption of less than half of a large kernel could
already exceed the ARfD in adults.
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Summary
Following a request from the European Commission, the EFSA Panel on Contaminants in the Food
Chain (CONTAM Panel) assessed acute risks to human health related to the presence of cyanogenic
glycosides (CNGs) in raw apricot kernels or products derived thereof.
Risk assessments from EFSA and other international and national scientiﬁc bodies on CNGs together
with the publications referenced therein have been used as a starting point for the identiﬁcation and
characterisation of acute health hazards of cyanide. In addition, a systematic literature search has
been carried out to obtain up-to-date and comprehensive information on hazards of CNGs and their
occurrence in apricot kernels and products thereof. No consumption data on apricot kernels were
available in the EFSA database. For hazard and exposure assessment the general principles for risk
assessment were followed.
Amygdalin is the major CNG present in apricot kernels. In intact apricot kernels, amygdalin and its
catabolic enzymes are stored in separate compartments and are brought into contact by physical
processes such as grinding or chewing thereby releasing hydrocyanic acid (HCN). Complete
degradation of 1 g of amygdalin releases 59 mg HCN. Because of its weak acidity, in aqueous
biological ﬂuids HCN always exists as a mixture of non-dissociated acid (HCN) and its dissociated form
(as cyanide anion or CN), the proportion of either depending on the pH in the ﬂuid. The term
cyanide, as used in the present assessment, thus represents dissociated and non-dissociated forms.
Amygdalin is also metabolised to cyanide in the intestinal tract by the gut microbiota.
Cyanide is readily absorbed reaching maximum blood levels within minutes and is distributed to all
organs. Its half-life in blood is usually less than 1 h. There are no pronounced species differences in
the toxicokinetics of cyanide. The primary mode of action by which cyanide exerts acute toxicity is the
inhibition of oxidative phosphorylation, in particular of cytochrome oxidase a3. Heart and brain are the
most sensitive organs because they require continuous supply of ATP generated by oxidative
phosphorylation.
Acute oral median lethal dose (LD50) values for cyanide in laboratory animals range from 2.13 to
6 mg/kg body weight (bw). Lethal levels of cyanide lead to dyspnoea, irregular and gasping breathing,
ataxia, tremor, spasms, loss of consciousness, convulsions and eventually asphyxiation. Short-term
dietary exposure to cyanide leads to histopathological changes and alterations in organ weights. For
cyanide a no observed adverse effect level (NOAEL) of 0.36 mg cyanide/kg bw per day [lowest
observed adverse effect level (LOAEL of 1.2 mg cyanide/kg bw per day)] was reported in rats. There
are indications that cyanide can act as a teratogen at higher doses.
In humans, the lethal oral dose of HCN is reported to be 0.5–3.5 mg/kg bw. A level of 0.5 mg/L
(approximately 20 micro mol, lM) of cyanide in blood is cited in the literature as a toxicity threshold in
humans. A series of poisoning cases are reported from ingestion of preparations containing amygdalin
and bitter apricot kernels. In adults, 20 or more kernels were reported to be toxic while the
corresponding number in children was ﬁve.
The animal data available did not provide a suitable basis for acute human health hazard
assessment. The CONTAM Panel concluded that the blood cyanide concentration of 20 lM, which is
reported to be a threshold for toxicity should be used as the basis for deriving the acute reference
dose (ARfD), extrapolating to an external dose of cyanide. In a bioavailability study, a group of 12
healthy adult volunteers consumed CNGs corresponding to 6.8 mg cyanide from a number of different
sources including bitter apricot kernels. A cyanide exposure of 0.105 mg/kg bw was estimated to result
in a mean peak blood level of 20 lM in the females in the study. The CONTAM Panel concluded that
the dose of 0.105 mg/kg bw, resulting in a blood concentration of about 20 lM in the females, should
be used as the basis for deriving the ARfD. Taking into account that it is assumed that CNGs are
completely broken down to cyanide and that the cyanide is rapidly absorbed and 100% bioavailable, it
is highly unlikely that individual variability could lead to appreciably higher peak blood levels. Because
of the very short time to peak blood level, individual differences in metabolism (e.g. due to reduced
activity of rhodanese) could delay elimination, but are unlikely to have an impact on the peak level.
The variations in peak blood levels seen in the study from Abraham et al. (2016) were small. Women
have a smaller distribution volume of blood than men and children have a larger blood volume (per
kg/bw) than adults. Therefore, the CONTAM Panel concluded that a default factor of 3.16 was not
required and that a factor of 1.5 was sufﬁcient to cover any additional variability in toxicokinetics. The
CONTAM Panel noted the lack of information on whether potentially sensitive individuals (e.g. children)
were included in the database underpinning the assumption that a blood cyanide level of 20 lM is a
toxicity threshold, and that the bioavailability study was conducted in a small number of healthy
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volunteers. The CONTAM Panel concluded that a toxicodynamic subfactor should be applied, and in the
absence of cyanide-speciﬁc data on individual sensitivity, adopted the default subfactor of 3.16.
Dividing the NOAEL of 0.105 mg/kg bw by the factors of 1.5 and 3.16, with rounding to a single
signiﬁcant ﬁgure, an ARfD for cyanide of 0.02 mg/kg bw (20 lg/kg bw) was established for use in
assessing the risks associated with the presence of CNGs in apricot kernels.
On the basis of information provided in the literature, an average kernel weight of 0.5 g and
cyanide concentrations ranging from 0.5 to 3.8 mg/g kernel were assumed for exposure assessment
and risk characterisation. The available information on amygdalin/cyanide content was not sufﬁcient to
discriminate between ‘bitter’ and ‘sweet’ apricot kernels. Due to lack of data it was not possible to
separately assess products containing raw apricot kernels or processed (e.g. ground, or without skin)
raw apricot kernels.
In the absence of consumption data, the highest number of kernels promoted by apricot kernel
vendors for the general population and cancer patients (10 and 60 kernels respectively) was used for
exposure assessment together with the highest and lowest mean values for cyanide concentrations in
apricot kernels described as ‘bitter’. For the general population, resulting exposures were 333 and
57 lg/kg bw assuming low cyanide content and 1,375 and 236 lg/kg bw assuming high cyanide
content, for toddlers and adults, respectively. For cancer patients, the corresponding numbers were
2,000 and 343 lg/kg bw and 8,250 and 1,414 lg/kg bw. In all scenarios, the ARfD of 20 lg/kg bw
was substantially exceeded.
Using the highest cyanide concentration in apricot kernels reported in the literature, the estimated
maximum quantity of apricot kernels (or raw apricot kernel material) that could be consumed by a
toddler without exceeding the ARfD was 0.06 g while an adult could eat up to 0.37 g. It is not
possible for consumers to measure such small quantities in the home. For a toddler, the ARfD would
be exceeded by consuming less than one small kernel. For adults, three very small kernels could be
consumed, but consumption of less than half of a large kernel could already exceed the ARfD.
The overall uncertainty incurred with the present assessment is considered as high. It is more likely
to overestimate than to underestimate the risk.
Information is needed on whether there is an objective distinction between ‘sweet’ and ‘bitter’
apricot kernels, and if so whether the cyanide contents differ. Data are also needed on the occurrence
of cyanide in whole raw apricot kernels and products derived from them. Furthermore, more
information is required on the impact of removing the skin and other forms of processing on the
cyanide content, as well as on consumption of products prepared from raw apricot kernels.
Cyanogenic glycosides in apricot kernels
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background
There has been a number of poisoning incidents in both Australia and New Zealand following
consumption of raw apricot kernels that contained high levels of hydrocyanic acid (HCN). This poses
an ongoing risk that needs to be managed to avoid future poisoning incidents.
In order to manage the potential risks of consumption of raw apricot kernels, Australia and
New-Zealand have prepared a draft food regulatory measure to prohibit the sale of raw apricot
kernels both with and without skin. This prohibition would also apply to any substance derived from
raw apricot kernels (ground, milled, cracked, chopped) with an exemption for apricots containing
raw apricot kernels, alcoholic beverages, oil, ﬂavourings, stone fruit juices, marzipan, cakes, biscuits
and confectionery.
The presence of HCN is regulated by Regulation (EC) No 1334/20081 in ﬂavourings and food
ingredients with ﬂavouring properties, in certain compound food as consumed to which ﬂavourings
and/or food ingredients with ﬂavouring ingredients with ﬂavouring properties have been added. A
maximum level of HCN of 50 mg/kg has been established in nougat, marzipan or its substitutes or
similar products, of 5 mg/kg in canned stoned fruits and of 35 mg/kg in alcoholic beverages.
Regulation (EC) No 110/20082 establishes a maximum content of HCN of 7 g/hL of 100% volume
alcohol in fruit marc spirit and stone fruit spirits.
There are no European Union (EU) provisions as regards the presence of HCN in (raw) apricot
kernels. The presence of very high levels of HCN in apricot kernels (between 333 and 2,545 mg/kg)
has been reported several times to the Rapid Alert System for Food and Feed (RASFF).
In the Expert Committee ‘Agricultural contaminants’ on 15 January 2015, the presence of HCN in
apricot kernels was acknowledged to be a potential acute health risk for consumers in the EU and
therefore restrictive measures at EU level might also be appropriate. The need for restrictive measures
in the frame of Regulation (EEC) 315/933 will be decided taking into account the outcome of a risk
assessment performed by the European Food Safety Authority (EFSA) on the acute health risk from
the presence of HCN in apricot kernels and derived products. The Standing Committee on Plants,
Animals, Food and Feed has been informed thereof at its meeting on 11 February 2015.4
1.1.2. Terms of Reference
In accordance with Art. 29 (1) (a) of Regulation (EC) No 178/2002, the Commission asks EFSA for
a scientiﬁc opinion on the acute human health risks related to the presence of HCN in apricot kernels
and products derived from apricot kernels (ground, milled, cracked, chopped).
1.2. Interpretation of the Terms of Reference
The EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) noted that free HCN is not
present in apricot kernels and that any risks are related to the release of HCN from cyanogenic
glycosides (CNGs) present in apricot kernels. Following the terms of reference provided by the
European Commission, only apricot kernels and products derived thereof that were not heat processed
or treated were considered in the assessment. Because of its weak acidity, HCN always exists as a
mixture of non-dissociated acid (HCN) and its dissociated form (cyanide ions, CN) in aqueous
biological ﬂuids, the proportion of either form in the dissociation equilibrium depending on the pH of
1 Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on ﬂavourings and certain
food ingredients with ﬂavouring properties for use in and on foods and amending Council Regulation (EEC) No 16011,
Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34–50.
2 Regulation (EC) No 110/2008 of the European Parliament and of the Council of 15 January 2008 on the deﬁnition, description,
presentation, labelling and the protection of geographical indications of spirit drinks and repealing Council Regulation (EEC)
No 1576/89. OJ L 39, 13.2.2008, p. 16–54.
3 Council Regulation (EEC) No 315/93 of 8 February 1993 laying down Community procedures for contaminants in food. OJ L 37,
13.2.1993, p. 1–3.
4 Summary report of the Standing Committee on Plants, Animals, Food and Feed, held in Brussels on 11 February 2015
(Section Toxicological Safety of the Food Chain), agenda item A.06. Report available at: http://ec.europa.eu/food/committees/
regulatory/scfcah/toxic/docs/sum_20150211_en.pdf
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the ﬂuid. Therefore, the term ‘cyanide’ will be used throughout this opinion to inclusively represent the
inorganic forms of cyanide, i.e. the undissociated HCN and the dissociated CN.
The CONTAM Panel also noted that apricot kernels are sometimes described as ‘bitter’ or ‘sweet’,
and decided to determine whether a distinction could be made between these.
1.3. Additional information
1.3.1. Chemistry
Hydrocyanic acid (hydrogen cyanide or HCN) does not occur in apricot kernels as free compound
but ‘hidden’ in the glycosides amygdalin and prunasin. Amygdalin and prunasin are members of a
large class of natural products called CNGs because they are enzymatically degraded when ingested
and release HCN, which exists in a dissociation equilibrium with CN in aqueous biological ﬂuids. The
mixture of non-dissociated HCN and cyanide ions is termed ‘cyanide’ (see Section 1.2) which is
the cause of the toxic effects of apricot kernels. Before discussing the chemistry of cyanide, the
chemistry of amygdalin, as well as its biosynthesis and degradation will be described brieﬂy.
Amygdalin is the trivial name for (R)-a-[(6-O-b-D-glucopyranosyl-b-Dglucopyranosyl)-oxy]-
(phenyl)acetonitrile, also named D-(-)-mandelonitrile-b-D-gentiobioside (Figure 1, left formula). It has
the Chemical Abstracts Service (CAS) number 29883-15-6, the molecular formula C20H27NO11, and a
molecular mass of 457.4 g mol1. Amygdalin is a colourless substance with a melting point of 213°C. It
is well soluble in ethanol, moderately soluble in water (83 g L1 at 25°C) and non-soluble in non-polar
solvents such as benzene or chloroform. The name vitamin B17 occasionally used for amygdalin is
erroneous, because it is not a vitamin. Amygdalin is also sometimes referred to as laetrile. This
designation is also wrong, as the real laetrile is (L-(-)-mandelonitrile-b-D-glucuronide, CAS number
1332-94-1), a semisynthetic cyanogenic glucuronide promoted as an alternative anticancer agent with
a chemical structure different from that of amygdalin (Figure 1, right formula).
The biosynthesis of amygdalin in plants follows the general scheme for CNGs i.e. consecutive
hydroxylation of an amino acid by cytochrome P450 (CYP) enzymes to an oxime and subsequently
a-hydroxynitrile, followed by glycosylation of the latter (Ganjewala et al., 2010; Gleadow and Møller,
2014). In the case of amygdalin (Figure 2), the amino acid phenylalanine is hydroxylated by a CYP79
enzyme to phenylacetaldoxime, which is further hydroxylated by a CYP71 enzyme to mandelonitrile.
Subsequent attachment of one glucose molecule to the a-hydroxyl group of mandelonitrile, catalysed
by a uridine diphosphate glucose-glucosyl transferase (UGT) leads to prunasin (D-(-)-mandelonitrile-
b-D-glucoside, CAS number 99-18-3, 295.3 g mol1), which is ﬁnally converted to amygdalin by
attaching another glucose molecule to the 6’-hydroxyl group, thereby forming the diglucoside
gentiobiose (Yamaguchi et al., 2014).
Neoamygdalin (CAS number 29883-16-7) is the S stereoisomer of amygdalin. It is not formed
during the biosynthesis of amygdalin in the apricot kernel but can be generated from amygdalin via
isomerisation of the stereogenic mandelonitrile carbon in aqueous solution under mild basic conditions
(Krieble, 1912; Wahab et al., 2015). Amygdalin (R-amygdalin) and neoamygdalin (S-amygdalin) are
diastereomers and not enantiomers because the conﬁgurations of the 10 stereogenic centres of their
gentiobiose moieties do not change (Wahab et al., 2015). As diastereomers, amygdalin and
neoamygdalin can be separated by chromatography on achiral stationary phases (see Section 1.3.2).
amygdalin                     laetrile
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Figure 1: Chemical structures of amygdalin and laetrile
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In contrast to CNGs, which are chemically stable and stored in plants, the biosynthetic intermediate
mandelonitrile (which is chemically a cyanohydrin or a-hydroxynitrile) is labile and able to
spontaneously dissociate into benzaldehyde and HCN would it not be stabilised by glycosylation. Thus,
if the glycosidic bond with mandelonitrile is hydrolysed, a process known as cyanogenesis is initiated
(Figure 3). The ﬁrst step in the degradation of amygdalin is mediated by the b-glucosidase amygdalin
hydrolase [Enzyme Commission Number (EC) 3.2.1.117] to yield prunasin and one glucose molecule.
Prunasin is then hydrolysed by another b-glucosidase named prunasin hydrolase (EC 3.2.1.21) to
mandelonitrile and glucose. The conversion of mandelonitrile to benzaldehyde and HCN proceeds
spontaneously at neutral or alkaline pH, but is much faster in the presence of the enzyme
mandelonitrile lyase (EC 4.1.2.10; Swain and Poulton, 1994). Complete hydrolysis of 1 g of amygdalin
generates 59 mg of HCN (FAO/WHO, 2012).
So far, no evidence for a ‘direct’ hydrolysis of amygdalin to mandelonitrile and gentiobiose has been
reported (Gleadow and Møller, 2014).
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Figure 2: Biosynthesis of amygdalin
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Figure 3: Formation of hydrocyanic acid from amygdalin and prunasin
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The process of cyanogenesis is sometimes also referred to as the ‘cyanide bomb’ (Morant and
Jørgensen, 2008). In intact plant cells, CNGs and their catabolic enzymes are stored in separate
compartments, but are brought into contact upon tissue disruption, caused e.g. by chewing or physical
processes such as maceration or freezing during food processing (Gleadow and Woodrow, 2002). The
strategy of handling CNGs and their catabolic enzymes as a binary system endows plants with an
effective defence against generalist herbivores. CNGs are therefore referred to as ‘phytoanticipins’.
Additionally, CNGs are believed to represent a pool of nitrogen to be used by the plant if needed
(Gleadow and Møller, 2014).
The hydrolysis of CNGs can involve various enzymes. In addition to the plant enzymes mentioned
above, b-glucosidases located in the mammalian intestinal epithelium and in colonic bacteria appear to
play an important role (see Section 3.1.1.1). The cyanide eventually released in the mammalian
gastrointestinal tract is detoxiﬁed through various pathways (see Section 3.1.1.1), and the toxicity of
amygdalin or any other CNG primarily depends on the rate of cyanide liberation versus cyanide
detoxiﬁcation.
Hydrocyanic acid is also named hydrogen cyanide, formonitrile, methanenitrile or prussic acid,
among others. It has the chemical formula HCN, the molecular mass 27.03 g mol1 and the CAS
number 74-90-8. In pure form, it is a colourless liquid with a boiling point of 25.6°C and a melting
point of 14°C. Its density is 0.687 g mL1 and its vapour pressure is 630 mmHg at 20°C. It is
completely miscible with water or ethanol. HCN is a very weak acid with a pKa of 9.2 and a pKb of 4.8,
and aqueous solutions of its alkali salts (cyanides) are therefore quite alkaline. HCN vapours have a
characteristic odour resembling bitter almond oil, but a high percentage of the population does not
readily smell HCN due to their genetic disposition.
1.3.2. Analytical methods
This article does not provide a full list of potential methods to quantify the concentration of
amygdalin or cyanide (originating from amygdalin) in apricot kernels and products derived from apricot
kernels. Rather, the intention is to identify methods that are used as the standard methods of analysis.
1.3.2.1. Quantiﬁcation of amygdalin
The extraction step from food samples is one crucial aspect of any analytical procedure due to the
potential of amygdalin for rapid degradation. It has been concluded that the extraction efﬁciency for
CNGs could vary considerably depending on the grinder and the extraction methods. In addition to
enzymatic degradation, amygdalin can epimerise to neoamygdalin in hot aqueous solutions (e.g.
Wasserkrug and Rassi, 1997; Hwang et al., 2002; Koo et al., 2005). Lee et al. (2013) reported that
approximately 35% of a 200 lg/kg amygdalin standard in methanol/water (40:60 v/v) converted to
neoamygdalin during the 24 h extraction process with methanol at room temperature. This might lead,
in some cases, to substantial underestimation of the amount of CNG. Water, water containing 0.1%
citric acid, methanol or ethanol are frequently used for amygdalin extraction (e.g. Lv et al., 2005;
Bolarinwa et al., 2014). High-performance liquid chromatography (HPLC) with ultraviolet (UV)
detection (HPLC-UV) and HPLC with diode-array detection (HPLC-DAD) have been widely applied to
quantify amygdalin in food samples after extraction. More recently, solid-phase extraction along with
liquid chromatography (LC)-tandem mass spectrometry (LC-MS/MS) analysis has been used, improving
both sensitivity and selectivity of the analyses (e.g. Lee et al., 2013). To selectively separate amygdalin
and neoamygdalin, Wahab et al. (2015) recommended the use of cyclodextrin chiral columns or
porous graphitic carbon columns. These authors demonstrated that the conversion of amygdalin to
neoamygdalin is glassware dependent and thus they recommended inert plastic containers for storage
of aqueous amygdalin solutions. Notably, in their study, commercial preparations of amygdalin
contained greater quantities of neoamygdalin and  5% of other degradation products. Besides LC-
based techniques, less frequently gas chromatography mass spectrometry (GC-MS) as well as enzyme-
linked immunosorbent assays (ELISAs) have been applied to quantify amygdalin in food (FAO/WHO,
2012; Bolarinwa et al., 2014).
1.3.2.2. Quantiﬁcation of cyanide (originating from amygdalin)
Crucial steps in the analysis of cyanide (originating from amygdalin) include sample handling and
complete hydrolysis of CNGs. Hydrolysis can be achieved by acid catalysis or enzymatic degradation.
For the latter, commercial glycosidases or enzyme preparations from animals and microorganisms are
frequently used (EFSA, 2007a). To ensure that all released HCN is retained for analysis, food samples
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should be incubated with the enzymes or the diluted acid in sealed containers. Methods of quantifying
the released cyanide include colorimetry, spectrophotometry and chromatography with subsequent
detection (FAO/WHO, 2012).
In the enzyme-based picrate method, HCN is liberated via exogenous enzymes and allowed to react
directly with sodium picrate paper strips suspended above the solution. After removing and immersing
the paper in water, the absorbance is measured (510 nm) to calculate the cyanide content. Haque and
Bradbury (2002) compared cyanide determination in 10 plants and food samples comparing the
enzyme-based picrate method and an acid hydrolysis method. The acid hydrolysis method detected
cyanide via a formed polymethine dye (600 nM) after the addition of chloramine-T and barbituric acid.
They concluded that the applied acid hydrolysis method is more difﬁcult to use as well as less accurate
and reproducible than the picrate method.
The ofﬁcial method of the Association of German Agricultural Analytic and Research Institutes for
cyanide determination in food and feed is based on acid hydrolysis, subsequent distillation of liberated
cyanide and titration (iodide/silver nitrate) (VDL-UFA, 1976).
Recently, FSANZ (2014) compared cyanide analysis in food samples via acid hydrolysis followed by
colorimetric detection of cyanide with a standardised HPLC with a ﬂuorescence detection-based
method for animal feeding materials (EU, 2012). The approved method involves extraction of CNGs
with an acid solution, enzymatic digestion applying b-glucosidase, collection of cyanide in a potassium
hydroxide solution by steam distillation, derivatisation of cyanide with taurine and 2,3 naphthylene
dicarboxy aldehyde and subsequent analysis of the ﬂuorescent cyanide complex by HPLC with
ﬂuorescence detection.
The authors concluded that the acid hydrolysis method is not appropriate for the measurement of
very low cyanide concentrations [limit of detection (LOD) 1.5–5 mg HCN/kg]. However, they
considered the acid hydrolysis robust for samples with high cyanide concentrations such as apricot
kernels. For the sensitive EU method (LOD 0.1 mg HCN/kg) to be applied for food samples with high
concentrations such as bitter apricot kernels, extracts need to be diluted substantially to bring them in
the measuring range (FSANZ, 2014).
1.3.3. Previous assessments
A total of three EFSA opinions pertinent to the current risk assessment have been published
previously. In the opinion on HCN in ﬂavourings and other food ingredients with ﬂavouring
properties, it was described that quantitative data on oral acute toxicity of HCN are limited to studies
in dogs and rats in which the medium lethal dose (LD50) was found to be 5.3 mg potassium cyanide
(KCN)/kg body weight (bw) and 10–15 mg KCN/kg bw equivalent to 2.13 and 4.0–6.03 mg CN/kg
bw, respectively. The lowest published lethal dose to humans is 0.56 mg HCN/kg bw. No safe intake
level with respect to the acute toxicity of HCN was established. The peak plasma levels of HCN
determine the acute toxicity. In case of intake of CNGs, HCN is slowly and incompletely released by
hydrolysis by gut micro ﬂora and then absorbed, and the acute toxicity for HCN will be lower than if
injected. The lethal oral dose of the CNG linamarin in rat was determined to be 450 mg linamarin/kg
bw. It was concluded that the estimated exposure to cyanide from ﬂavouring ingredients (at the
97.5th percentile of 3.6 lg/kg bw per day) was unlikely to give rise to acute toxicity in humans
(EFSA, 2004).
As HCN is one of several precursors of ethyl carbamate formation, EFSA also considered this
compound in the opinion on the presence of ethyl carbamate and HCN in food and beverages (EFSA,
2007a). However, for risk assessment purposes and conclusions, direct reference was made to the
opinion on HCN in ﬂavourings and other food ingredients with ﬂavouring properties (EFSA, 2004).
In another EFSA opinion on cyanogenic compounds as undesirable contaminants in animal feed,
speciﬁc values in the lower mg HCN equivalents per kg body weight per day range were deﬁned that
were considered tolerable in a number of species. This report also mentioned intravenous (i.v.) LD50
values for several species, ranging from 0.78 mg CN/kg bw for rat to 1.38 mg CN/kg bw for guinea pig
(EFSA, 2007b).
In their assessment, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) concluded
that the data from human epidemiological studies were insufﬁcient to form the basis for establishing a
health-based guidance value. Accordingly, JECFA used an animal developmental toxicity study as the
basis for deriving an acute reference dose (ARfD) for the CNG linamarin. Benchmark dose modelling of
the data from that particular study provided a 95% lower limit on the benchmark dose for a 10%
response (BMDL10) for linamarin of 85 mg/kg bw for increased skeletal defects in developing hamster
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foetuses following acute exposure of maternal animals. While this study did not use dietary exposure,
gavage dosing was considered relevant to establishing the ARfD. Following application of a 100-fold
uncertainty factor (UF), JECFA established an ARfD for linamarin of 0.9 mg/kg bw equivalent to
0.09 mg/kg bw as CN. When compared on a CN molar basis, this value was considered to also be
applicable to other CNGs. Therefore, JECFA recommended conversion of the ARfD for linamarin to a
CN equivalent dose of 0.09 mg/kg bw. This CN equivalent ARfD applies only to foods containing CNGs
as the main source of CN. JECFA (FAO/WHO, 2012) also established a Provisional Maximum Tolerable
Daily Intake (PMTDI) of 20 lg/kg bw CN based on ﬁndings in a 13-week toxicity study on sodium
cyanide conducted by the US National Toxicology Program (NTP).
The UK Committee on the Toxicity of Chemicals in Food, Consumer Products and Environment
(COT) proposed an ARfD of 5 lg CN/kg bw, which was obtained by dividing the acute lethal dose of
CN in humans (i.e. 0.5–3.5 mg/kg bw) by 100. This UF comprised a factor of 10 for interindividual
variability and another factor of 10 to extrapolate from an effect level to a no-effect level because of
the steep dose–response relationship. Bitter apricot kernels typically contain approximately 0.5 mg
CN/kernel. Thus, consumption of 1 kernel/day would result in a CN intake of 0.5 mg/day, which is
equivalent to 8 lg CN/kg bw for an adult weighing 60 kg and that approximates the proposed ARfD
(COT, 2006).
The Hellenic Food Authority (EFET) also considered 0.5 mg CN per bitter apricot kernel and a
PMTDI of 12–20 lg CN/kg bw, which is based on the TDI set by the WHO (1993) in the context of
developing drinking water guidelines (WHO, 2003) and the JECFA PMTDI (FAO/WHO, 2012). On the
basis of this information, EFET recommended that the maximum daily intake for adults is up to two
bitter apricot kernels and that children as well as pregnant women and breastfeeding mothers should
avoid consuming bitter apricot kernels. Given the ﬂuctuations in the concentration of CNGs in bitter
apricot kernels, EFET advises food companies to mention on the product packaging the maximum
quantity that can be safely consumed (EFET, 2014).
To determine the risk associated with the estimated dietary exposures, the Food Standards
Australia New Zealand (FSANZ) used an ARfD of 80 lg HCN/kg bw, which was obtained from their
previous assessment on HCN in cassava chips. The principal CNG in cassava is linamarin. For linamarin,
an ARfD of 700 lg/kg bw was established on the basis of death in hamsters at doses greater than
70 mg/kg bw and applying a 100-fold UF to account for intraspecies variability and interspecies
extrapolation. The available data indicate that no unchanged linamarin is excreted in the faeces
following oral ingestion, thus suggesting that there is sufﬁcient enzymatic capacity in the microﬂora of
the caecum to completely hydrolyse large amounts of linamarin. As total HCN levels are more readily
determined than linamarin levels, the linamarin ARfD was converted to an ARfD for total HCN
measured in cassava as an analytical convenience. The linamarin ARfD equates to an ARfD for HCN in
cassava of 80 lg HCN/kg bw (FSANZ, 2008). For use with respect to apricot kernels, a distinction was
made between kernels with or without skin, containing 2,820 and 440 mg HCN/kg kernel, respectively.
Assuming that one kernel weighs approximately 0.6 g, speciﬁc recommendations were made with
respect to maximum daily consumption per age class (FSANZ, 2014).
The German Federal Institute for Risk Assessment (BfR) assumed that bitter apricot kernels contain
up to 4 mg chemically bound cyanide per kernel, which corresponds with 1.5 mg of cyanide per
medium-sized apricot kernel and up to 3.0 mg cyanide per large apricot kernel. Keeping in mind that
the fatal dose of cyanide in humans is around 0.5–3.5 mg/kg bw, BfR derived an ARfD of 75 lg
cyanide/kg bw. This dose (i.e. 4.5 mg for a bw of 60 kg) is safe when a meal is eaten and is
equivalent to approximately two large bitter apricot kernels in adults. The ARfD was derived from a
study in human volunteers after consumption of foods containing high levels of CNGs, including bitter
apricot kernels, containing equivalents of 6.8 mg CN. The highest peak level of cyanide in blood was
31.9 lM in a person weighing 60 kg after consumption of cassava. In this individual, 6.8 mg CN
corresponded to a dose of 0.113 mg/kg bw. Roughly, two thirds of this dose (i.e. 75 lg CN/kg bw)
would have resulted in a CN peak level of 20 lM (which was assumed to be the threshold for toxicity)
in this person. The application of any further safety factors was not judged to be necessary, as peak
levels were found to be mainly determined by the body weight deﬁning the volume of distribution,
whereas mechanisms of elimination, such as activity of rhodanese with possible higher variability, are
unimportant for peak levels in case of a bolus application of a relatively high dose of CN (BfR, 2015;
Abraham et al., 2016).
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1.3.4. Legislation
Council Regulation (EEC) No 315/935 stipulates that food containing a contaminant in an amount
unacceptable for public health shall not be placed on the market, that contaminant levels should be
kept as low as can reasonably be achieved and that, if necessary, the EC may establish maximum
levels for speciﬁc contaminants. These maximum levels are laid down in the Annex of Commission
Regulation (EC) No 1881/20066 and may include limits for the same contaminants in different foods,
analytical detection limits and reference to the sampling and analysis methods to be used. There are
no EU maximum levels established for cyanide in raw apricot kernels and/or products thereof.
Regulation (EC) No 1334/20087 governs the use of ﬂavourings and food ingredients with ﬂavouring
properties in foods. The regulation also provides maximum levels of certain substances naturally
present in ﬂavourings and food ingredients with ﬂavouring properties. A maximum level for HCN of
50 mg/kg has been established for nougat, marzipan or its substitutes or similar products, of 5 mg/kg
in canned stone fruits and of 35 mg/kg in alcoholic beverages.
Regulation (EC) No 110/20088 governs the deﬁnition, description, presentation, labelling and
protection of geographical indications of spirit drinks and establishes a maximum content of HCN of
7 g/hL of 100% volume alcohol (70 mg/L) in stone-fruit marc spirits and stone-fruit spirits.
Cyanogenic glycosides are mentioned in medicines legislation of some Member States. For example,
the UK Human Medicines Regulations 20129 stipulate that cyanogenic substances, other than
preparations for external use, shall only be available on prescription. Cyanogenic substances are deﬁned
therein as preparations which are presented for sale or supply under the name of, or as containing,
amygdalin, laetrile, vitamin B17, or contain more than 0.1% by weight of any substance having the
formula either of a-cyanobenzyl-6-O-b-D-glucopyranosyl-b-D-glucopyranoside, or a-cyanobenzyl-b-D-
glucopyranosiduronic acid. Medicinal products containing amygdalin or its derivatives mandelonitrile,
mandelonitrile-glycoside or laetrile are not authorised in Germany. According to the Federal Institute for
Drugs and Medical Devices, such medical products are to be classiﬁed as dangerous according to
paragraph 5.2 of the Medicinal Products Act10 and must not be placed on the market or be applied to
individuals even if a medical prescription is available.
In Australia and New Zealand, raw apricot kernels which are deﬁned as hulled, dehulled, blanched,
ground, milled, cracked, chopped or whole kernels of Prunus armeniaca must not be sold in a retail
sale and must not be used as an ingredient in food unless they have been processed rendering them
safe for human consumption.11
2. Data and methodologies
2.1. Data
2.1.1. Occurrence data
EFSA gathers at the EU-level data on the occurrence of chemical substances in food and feed
through continuous collections and/or calls for particular assessments. No data concerning cyanide
occurrence in apricot kernels were available in the EFSA occurrence database. A literature review was
carried out in order to collect published data. Collection and appraisal of occurrence data was carried
out as described in Section 2.2.2.
5 Council Regulation (EEC) No 315/93 of February 1993 laying down Community procedures for contaminants in food. OJ L 37,
13.2.1993, p. 1–5.
6 Regulation (EC) No 1881/2006 of the European Parliament and the Council of 19 December 2006 setting maximum levels for
certain contaminants in foodstuffs. OJ L 364, 20.12.2006, p. 5–24.
7 Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on ﬂavourings and certain
food ingredients with ﬂavouring properties for use in and on foods and amending Council Regulation (EEC) No 160/1,
Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC (OJ L 354, 31.12.2008, p. 34–50).
8 Regulation (EC) No 110/2008 of the European Parliament and of the Council of 15 January 2008 on the deﬁnition, description,
presentation, labelling and the protection of geographical indications of spirit drinks and repealing Council Regulation (EEC)
No 1576/89. OJ L 39, 13.2.2008, p. 16.
9 http://www.legislation.gov.uk/uksi/2012/1916/pdfs/uksi_20121916_en.pdf
10 http://www.gesetze-im-internet.de/amg_1976/BJNR024480976.html
11 http://www.foodstandards.gov.au/code/changes/gazette/Documents/GazetteNo159WebVersion.pdf
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2.1.2. Consumption data
Since 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive
Database) has been populated with national data on food consumption at a detailed level. Competent
authorities in the European countries provide EFSA with data on the level of food consumption by the
individual consumer from the most recent national dietary survey in their country. This is described in
the guidance on the use of the EFSA Comprehensive European Food Consumption Database in
Exposure Assessment (EFSA, 2011). New consumption surveys have been recently added in the
Comprehensive Database (at the end of 2014).
Within the Comprehensive Database, only one subject, a child (body weight of 15 kg) in a survey
conducted in Bulgaria, reported the consumption of 50 g (3.3 g/kg bw) of apricot kernels, without
specifying if bitter or sweet, nor if treated prior to consumption. Therefore, data available in the
Comprehensive Database concerning the consumption of apricot kernels were insufﬁcient to estimate
the dietary exposure to cyanide in the current assessment.
Consequently, websites promoting the consumption of apricot kernels and products thereof were
searched for an overview of the promoted amounts of apricot kernels to be ingested.
2.1.3. Toxicokinetic and toxicological data
All data were obtained as described in Section 2.2.1.
2.2. Methodologies
2.2.1. Collection and appraisal of occurrence, toxicokinetics and toxicity data
In 2004, EFSA published a scientiﬁc opinion of the Panel on Food Additives, Flavourings, Processing
Aids and Materials in Contact with Food (AFC Panel) on HCN in ﬂavourings and other food ingredients
with ﬂavouring properties (EFSA, 2004). It was assumed that all relevant literature until that date was
considered for this previous assessment. Literature (no time limit was applied) referenced therein on
chemistry and analysis, metabolism and kinetics, food processing and oral acute-, and sub-acute
toxicity of cyanide, amygdalin and apricot kernels has been evaluated, and considered or dismissed by
expert judgement for the present assessment (a total of 53 publications). Studies on genotoxicity
and chronic toxicity, on CNGs not present in apricot kernels (such as linamarin present in cassava) and
on cassava were not considered. Any limitations of the information used are documented in this
opinion.
In 2007, EFSA published a scientiﬁc opinion on cyanogenic compounds as undesirable substances in
animal feed (EFSA, 2007b). Likewise have publications referenced therein been considered for the
present assessment following selection criteria as described above, yielding a total of additional 16
publications to be considered. In the same year EFSA published a scientiﬁc opinion on ethyl carbamate
and HCN in food and beverages (EFSA, 2007a). For the hazard characterisation in this opinion, EFSA
referred to the conclusions of the previous EFSA opinion of the AFC Panel (EFSA, 2004) and additional
data that had become available since then. Upon reviewing the references in this opinion applying the
selection criteria described above, no further publications relevant for the present assessment have
been identiﬁed.
In order to retrieve relevant information made available after publication of the ﬁrst EFSA opinion
dealing with cyanide (EFSA, 2004), the CONTAM Panel retrieved and appraised literature made publicly
available between January 2004 and June 2015. A systematic and comprehensive search for literature
was conducted for peer-reviewed original research pertaining to HCN in raw apricot kernels and
products derived thereof. The search strategy was designed to identify scientiﬁc literature dealing with
analytical determination, chemistry, formation, occurrence and exposure, metabolism and toxicity of
HCN. In addition, literature covering food and processing was included. The search terms HCN and
cyanide were excluded from the search, due to a high number of scientiﬁc literature covering
non-cyanide-related uses of the abbreviation HCN and non-apricot kernel-related cyanide. All search
terms and Boolean operators used are presented in detail in Appendix A. In addition to HCN, the
search string covered any other potential term used, such as CNGs, amygdalin, prunasin, prussic acid,
laetrile, formonitrile and vitamin B17. Literature search was not restricted to publications in English
language; however, literature in other languages was only considered if an English abstract was
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available. The literature search was performed on 4 June 2015. Web of Science12 and Pubmed13
were identiﬁed as databases appropriate and exhaustive for retrieving literature for the present
evaluation.
The references resulting from the literature search were imported and saved using a software
package (EndNote14), which allows effective management of references and citations. Of the 4,117
retrieved citations, duplicate references were removed using the EndNote software. The remaining
1,733 references were screened using title and abstract to identify the relevant literature. Using expert
judgement, 75 publications were identiﬁed as relevant to apricot kernels and considered for the
present assessment.
In addition to this ﬁrst search, a second search was carried out to include the search terms ‘bitter
apricot’ and ‘apricot paste’ covering the period 1 January 2004–4 September 2015 and covering all topics
and using the same Boolean operators as in the initial search. Of the 731 references retrieved, duplicates
were removed using the EndNote software, and the remaining 401 references were screened using title
and abstract (see Appendix A). Upon appraisal of the studies following inclusion/exclusion criteria as
described above and by applying expert judgement, an additional 17 publications were identiﬁed as
relevant, retrieved and considered for the assessment.
In addition, other previous scientiﬁc evaluations by national or international bodies were also
screened for relevant information.
These were:
• Hydrogen cyanide, sodium cyanide and potassium cyanide (DECOS, 2002)
• Hydrogen cyanide and cyanides: Human health aspects (WHO, 2004)
• Statement on cyanogenic glycosides in bitter apricot kernels (COT, 2006)
• Toxicological proﬁle for cyanide (ATSDR, 2006)
• Toxicological review of HCN and cyanide salts (US EPA, 2010)
• Safety evaluation of certain food additives and contaminants: Cyanogenic glucosides (FAO/WHO,
2012)
• Survey of cyanogenic glycosides in plant-based foods in Australia and New Zealand 2010–2013
(FSANZ, 2014)
• Risk assessment of the presence of CN ions in bitter almonds and apricot kernels for consumer
health and recommendations for consumption of such products by adults and children (EFET,
2014)
• Two bitter apricot kernels per day are the limit for adults – children should avoid them
altogether – updated opinion No 009/2015 of 7 April 2015 (BfR, 2015; Abraham et al., 2016).
These assessments and the publications referenced therein were considered when relevant using
the inclusion/exclusion criteria described above and applying expert judgement.
During the development of the opinion, additional relevant publications not retrieved in the above-
mentioned literature (e.g. studies relevant to the assessment on receptor binding) assessment have
been identiﬁed and considered for the assessment.
2.2.2. Methodology applied for hazard assessment
The CONTAM Panel applied the general principles of the risk assessment process for chemicals in
food as described by WHO (2009), which include hazard identiﬁcation and characterisation, exposure
assessment and risk characterisation. Additionally to the principles described by WHO (2009), EFSA
guidance pertaining to risk assessment has been applied for the present assessment. In brief, the
EFSA guidance covers the procedures currently used within EFSA for the assessment of dietary
exposure to different chemical substances and the uncertainties arising from such assessments. For
details on the speciﬁc EFSA guidances applied, see Appendix B.
12 Web of Science (WoS), formally ISI Web of Knowledge, Thomson Reuters (http://thomsonreuters.com/thomson-reuters-web-
of-science/).
13 PubMed, Entrez Global Query Cross-Database Search System, National Center for Biotechnology Information (NCBI), National
Library of Medicine (NLM), Department of the National Institutes of Health (NIH), United States Department of Health and
Human Services (http://www.ncbi.nlm.nih.gov/pubmed/).
14 EndNote X5, Thomson Reuters. http://endnote.com/
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2.2.3. Exposure assessment
Following EFSA guidelines (EFSA Scientiﬁc Committee, 2012), the Panel decided to estimate the
exposure to cyanide via the consumption of raw apricot kernels separately for toddlers and adults. This
encompasses dietary exposures of older children and adolescents, which are generally likely to
be intermediate between those of adults and toddlers (EFSA Scientiﬁc Committee, 2012). For ‘Adults’
(18–64 years old), a standard weight of 70 kg was used, while for the group ‘Toddlers’ (aged 1–3 years),
a weight of 12 kg was considered (EFSA Scientiﬁc Committee, 2012).
Due to the lack of consumption data, the Panel decided to perform an exposure assessment using
the highest portion size promoted from the websites promoting the consumption of apricot kernels for
the general population and highest portion size promoted for cancer patients (see Section 3.2).
Potential exposure to cyanide (originating from amygdalin) due to the consumption of apricot
kernels in the general population and in cancer patients for toddlers and adults was estimated through
the following scenarios:
1) In the ﬁrst scenario, it was assumed that the apricot kernels’ cyanide concentration was equal
to the lowest cyanide mean concentration level available in the literature for bitter apricot
kernels.
2) In the second scenario, it was assumed that the apricot kernels’ cyanide concentration was
equal to the upper cyanide mean concentration level available in the literature for bitter apricot
kernels (see Section 3.3).
Mean values were considered appropriate in both scenarios as the cyanide content of individual
kernels varies and if a large number of kernels are consumed, it is unlikely that all will contain cyanide
at the maximum reported level (see also Section 3.3).
In both exposure scenarios, the midpoint of the mean weight for apricot kernels reported in the
literature was used (see Section 3.3).
3. Assessment
3.1. Hazard assessment
3.1.1. Toxicokinetics and metabolism
The health hazard posed by apricot kernels is due to cyanide. As described earlier (Section 1.3.1),
intact apricot kernels do not contain free cyanide but the CNG amygdalin. Upon mechanical or thermal
disruption of the kernel tissue, plant enzymes are set free which hydrolyse amygdalin to prunasin and
eventually lead to the release of HCN (Figure 3). Complete hydrolysis of 1 g of amygdalin generates
59.0 mg of HCN (FAO/WHO, 2012).
Orally ingested apricot kernels which have been chewed or processed may contain a mixture of
compounds ranging from amygdalin to free HCN and cyanide ions, including the intermediates of
degradation. Because the degrading plant enzymes, i.e. amygdalin hydrolase (AH), prunasin hydrolase
(PH) and mandelonitrile lyase (MNL) (Figure 3), are presumably inactivated by the acidic pH of the
stomach, the components of the mixture can either be absorbed as such or after metabolism by
mammalian or bacterial enzymes present in the gastrointestinal tract.
The toxicokinetics and metabolism of cyanides have been well studied, because these agents are
important industrial chemicals as well as military and environmental toxins, occurring e.g. in cigarette
smoke and as combustion products of nitrogen-containing plastics. In comparison, little is known
about the toxicokinetics of amygdalin and prunasin and their intermediate degradation products.
3.1.1.1. Laboratory animals
Toxicokinetic studies in laboratory animals have been performed with pure amygdalin, prunasin or
cyanide. One study with mandelonitrile in horses has been identiﬁed.
When a single dose of 50 mg amygdalin/kg bw was administered by oral gavage to young Beagle
dogs of both sexes, plasma levels and urinary excretion of unchanged amygdalin were very low, and
the systemic availability was estimated to be only 2.2  0.3% of the dose (Rauws et al., 1982). In
contrast, an appreciable quantity (21  9% of the dose) was excreted in the 6-h urine as prunasin.
Likewise, after oral administration of the same dosage of amygdalin to male and female Wistar rats,
0.8  0.5% of the dose was excreted unchanged and 39  9% as prunasin with the urine (Rauws
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et al., 1982). When the same dose of amygdalin was given to dogs by the i.v. route, 71  8% of the
dose was excreted unchanged and < 0.2% as prunasin in the 6-h urine. This study implies that the
absorption of intact amygdalin in the gastrointestinal tract is rather limited, but part of the amygdalin
appears to be hydrolysed to prunasin in the intestine. In support of this notion, an in vitro study using
isolated perfused segments of rat small intestine showed an appreciable hydrolysis of amygdalin to
prunasin in the proximal jejunum (Strugala et al., 1986). There were no indications of the further
metabolism of prunasin to benzaldehyde. The hydrolysis of amygdalin to prunasin was also observed
in incubations with mucosal homogenates from the upper small intestine. It was pH-dependent and
could be inhibited by glucono-d-lactone, which is known as a potent inhibitor of lysosomal
b-glucosidase activity in the rat intestine. The common glycosylases of the mammalian intestine, e.g.
a-amylase and a-glucosidase, and mammalian liver, e.g. b-glucuronidase and b-galactosidase, did not
catalyse the hydrolysis of amygdalin to prunasin. Moreover, no hydrolysis of amygdalin or prunasin
could be observed in isolated perfused rat liver. However, the faecal contents of rats hydrolysed both
amygdalin and prunasin, and the released mandelonitrile disintegrated spontaneously into cyanide and
benzaldehyde (Strugala et al., 1986). The authors concluded that amygdalin itself is not absorbed to
an appreciable amount in the gastrointestinal tract, but hydrolysed to prunasin in the jejunum, which
is then absorbed and subsequently excreted in the urine without releasing appreciable amounts of
cyanide. The toxicity of amygdalin and prunasin due to the release of cyanide appeared to require the
enzymatic activity of the gut ﬂora.
A later in vitro study (Strugala et al., 1995) also indicated that prunasin is transferred intact, i.e.
without hydrolysis and formation of cyanide, across the intestinal wall of the rat jejunum and ileum.
The transfer in the jejunum exhibited saturation and interfered with the uptake of methyl
a-D-glucoside, implying the participation of a glucose transporter. Transfer of prunasin in the ileum
exhibited characteristics of passive diffusion. When Wagner and Galey (2003) studied the effect of
amygdalin and prunasin on the transport of glucose in the rat jejunum, prunasin, but not amygdalin,
was found to reduce the inﬂux of glucose, consistent with the hypothesis that only prunasin is
carried across the gut mucosa via the epithelial sodium-dependent monosaccharide transporter
SGLT1.
Consistent with the virtual lack of absorption of intact amygdalin and the metabolism to prunasin is
the ﬁnding by Chen et al. (2012) that no amygdalin but a delayed peak of prunasin could be found by
HPLC-UV analysis in rat plasma after oral gavage dosing of amygdalin.
Convincing evidence for an important role of the gastrointestinal micro ﬂora in the release of cyanide
from amygdalin was provided by Carter et al. (1980). Adult conventional Sprague-Dawley rats, i.e. rats
with an intact bacterial ﬂora, and germfree rats, which lack this ﬂora, received the same dose of
amygdalin (600 mg/kg bw) by gastric intubation. The germfree rats did not have detectable levels of
cyanide in the blood and did not exhibit symptoms of cyanide intoxication, while the conventional rats
had high levels of cyanide and some died within a few hours. Levels of thiocyanate, the major metabolite
of cyanide (see below), paralleled that of cyanide. When amygdalin was incubated with the caecal
contents of conventional rats, ca. 40% of the amygdalin was degraded after 24 h with the concomitant
formation of benzaldehyde, while no degradation was observed with the caecal content of germfree rats.
The importance of the gut microbiota for the release of cyanide from orally dosed amygdalin was also
demonstrated by Newton et al. (1981). When female Fischer 344 rats were pretreated with the antibiotic
neomycin prior to an oral dose of amygdalin, almost no thiocyanate was detectable in the 24-h urine,
while rats with an intact bacterial ﬂora excreted a large amount of thiocyanate under the same
conditions. In the same study, various segments of the rat gastrointestinal tract were incubated with
amygdalin and the generation of cyanide was measured. The highest activity for cyanide formation was
observed for the rat caecum and the lowest for the rat stomach.
Frakes et al. (1986) studied cyanide liberation during incubation of equimolar concentrations of
amygdalin and prunasin with a crude preparation of b-glucosidase obtained from the pooled caeca and
their contents of female golden hamsters. Prunasin was hydrolysed more than twofold faster than
amygdalin. When amygdalin was administered to female hamsters at a dose of 0.44 mmol/kg bw
(corresponding to 200 mg/kg bw) by oral gavage, the blood cyanide concentration reached a transient
plateau (at about 150 nmol/mL) and was accompanied by symptoms of cyanide poisoning in most
animals (Frakes et al., 1986).
Majak and Cheng (1987) reported that rumen ﬂuid from cattle also degraded amygdalin and
prunasin to cyanide. The rate of cyanogenesis was found to depend on the cattle diet but was always
about twofold higher for prunasin than for amygdalin. Thirty out of 68 common strains of anaerobic
rumen bacteria were shown to exhibit cyanogenic activity (Majak and Cheng, 1984).
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When mandelonitrile was orally administered at a dose of 3 mg/kg bw to horses, peak blood
concentrations of cyanide (about 70 mM) were observed as early as 3 min after dosing, followed by a
rapid decline; no signs of cyanide intoxication or distress were observed, and the oral bioavailability of
cyanide from mandelonitrile was 57% (Dirikolu et al., 2003).
The animal studies outlined above shown that orally administered amygdalin is virtually not
absorbed per se, but partly hydrolysed by mammalian b-glucuronidase in the jejunum to prunasin,
which is then absorbed utilising the glucose transporter. Amygdalin and prunasin reaching the caecum
are efﬁciently hydrolysed by the bacterial microﬂora, resulting in the release of cyanide. For the toxicity
of CNGs, the liberation of cyanide in the caecum appears to be of critical importance.
As HCN is a very weak acid with a pKa of 9.2, cyanide-containing material leads to non-dissociated
HCN in every part of the gastrointestinal tract. Non-dissociated HCN is a small and non-polar molecule
which is readily absorbed through the gastric and intestinal mucosa. In the blood, most of the cyanide
is conﬁned to the erythrocytes where it binds to methaemoglobin (Vesey et al., 1979; Lundquist et al.,
1985). The proportion of HCN escaping ﬁrst-pass metabolism in the liver (see below) is rapidly
distributed via the systemic circulation into all tissues. A complete analysis of the body distribution in
cadavers of animals and humans poisoned with cyanide showed roughly 50% of the absorbed cyanide
to be in the blood, about 25% in muscles and 25% in all the other organs together, predominantly in
the liver and brain (Schulz, 1984). After oral administration of a single dose of 3.0 mg KCN/kg bw to
rats, pigs and goats, the half-life of cyanide in blood was 0.64, 0.54 and 1.28 h and the volume of
distribution was 0.35, 0.29 and 0.41 L/kg, respectively (Sousa et al., 2003). In another study with rats,
the peak blood level of cyanide was observed 2 min after intragastric administration of 1 mg KCN/kg
bw, and a blood elimination half-life of 0.23 h was calculated (Leuschner et al., 1991).
The mammalian organism has developed several metabolic pathways in order to detoxify cyanide
(Figure 4). In the presence of a sulfur donor, e.g. thiosulfate, and a sulfur transferase, e.g. rhodanese
(see below), about 70% of a dose of cyanide is metabolised to thiocyanate (Sousa et al., 2003). The
transformation to thiocyanate represents a detoxiﬁcation of cyanide, because thiocyanate does not
block the electron transport in the mitochondrial respiratory chain. The acute toxicity of thiocyanate is
about 100-fold lower than that of cyanide, based on the oral LD50 in rats (Bilska-Wilkosz et al., 2015).
Cyanide can also react with L-cysteine through the putative intermediate b-thiocyanoalanine to
2-amino-2-thiazoline-4-carboxylic acid (ATCA). This pathway accounts for about 15–20% of cyanide
metabolism (Wood and Cooley, 1956). Thiocyanate and ATCA are chemically stable metabolites which
are not further metabolised but excreted with the urine (Bhandari et al., 2014). Another detoxiﬁcation
pathway is the reaction of cyanide with endogenous a-ketoglutarate (a-KG) to form a-ketoglutarate
cyanhydrin (a-KGCN). This pathway is assumed to become important when the thiocyanate and ATCA
pathways are overwhelmed (Mitchell et al., 2013). Other minor pathways, which are of interest
primarily as biomarkers for exposure (see Section 3.1.1.3), have also been described, e.g. the reaction
with cysteine disulﬁde groups in serum albumin (Fasco et al., 2007, 2011). In addition to binding to
methaemoglobin, cyanide binds to hydroxocobalamin (vitamin B12b). The complex of cyanide with
hydroxocobalamin is excreted with the urine. This binding can be used in the treatment of cyanide
poisoning by inducing methaemoglobinaemia or administering hydroxocobalamin (Way, 1984;
Petrikovics et al., 2015).
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Figure 4: Detoxiﬁcation of cyanide ions
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Whereas the formation of ATCA and a-KGCN proceeds without the help of enzymes, the primary
detoxiﬁcation pathway of cyanide, i.e. formation of thiocyanate, appears to be mediated by three
enzymes (see Figure 5).
The ﬁrst enzyme is thiosulfate:cyanide sulfurtransferase (EC 2.8.1.1), also termed rhodanese, which
transfers sulfur from a sulfane sulfur source (see below) such as thiosulfate to cyanide (Wrobel et. al.,
2004). The second enzyme, i.e. 3-mercaptopyruvate:cyanide sulfurtransferase (EC 2.8.1.2, MPST),
catalyses the transfer of sulfur from 3-mercaptopyruvate to a variety of sulfur acceptors, including sulﬁte
and cyanide (Jarabak and Westley, 1980). Thereby, MPST can provide thiosulfate to rhodanese (Fig. 5),
but also directly convert cyanide to thiocyanate. 3-Mercaptopyruvate is formed through transamination
of cysteine. The third enzyme, i.e. cystathione c-lyase (EC 4.4.1.1., cystathionase), converts cysteine to
thiocysteine and thiocysteine, which also serve as sulfane sulfur donor substrates for rhodanese (Baskin
et al., 1999). Sulfane sulfur is a divalent sulfur atom covalently bound to another sulfur atom, and most
sulfane sulphur-containing compounds are endogenous metabolites formed from cysteine. Bilska-Wilkosz
et al. (2015) recently reported that lipoic acid, a naturally occurring dithiol compound, increased the rate
of thiocyanate excretion in rats dosed with cyanide, suggesting that lipoic acid may also be involved in
cyanide detoxiﬁcation.
Rhodanese is a ubiquitous enzyme present in many tissues of humans and other species
(Drawbaugh and Marrs, 1987). The highest activities are commonly measured in the liver and kidneys.
However, in sheep and cattle, the epithelium of rumen, omasum and reticulum has the highest activity
(Aminlari and Gilanpour, 1991). Within the cell, rhodanese is located predominantly in the
mitochondria. In humans, polymorphic variants of rhodanese have been characterised (Libiad et al.,
2015). Species differences in rhodanese activity have been reported (e.g. Drawbaugh and Marrs,
1987; Aminlari and Gilanpour, 1991), but cannot be directly correlated with the sensitivity to cyanide
because of the participation of other enzymes and pathways in cyanide detoxiﬁcation. Moreover,
the availability of sulfur donors is of paramount importance for the rate of detoxiﬁcation of cyanide.
The major sulfur donors are the sulfur-containing amino acids cysteine and methionine, which provide
the sulfur to form thiosulfate from sulﬁte in the cells. Orally administered thiosulfate is very poorly
absorbed from the gastrointestinal tract, and even after i.v. administration remains mostly in the
extracellular space (Schulz, 1984). In support of the importance of dietary sulfur amino acids for
cyanide detoxiﬁcation, Kimani et al. (2014) observed a markedly lower rate of cyanide detoxiﬁcation in
the spinal cord of rats after feeding a diet lacking 75% of sulfur amino acids as compared to a normal
diet.
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Figure 5: Various pathways leading to compounds with sulfane sulfur
Cyanogenic glycosides in apricot kernels
www.efsa.europa.eu/efsajournal 19 EFSA Journal 2016;14(4):4424
3.1.1.2. Humans
Because of the putative anticancer activity of amygdalin, most toxicokinetic studies in humans were
conducted with cancer patients, using i.v. injections which are not relevant to oral administration.
Ames et al. (1981) determined the plasma and urine concentrations of amygdalin, whole-blood
concentration of cyanide, and thiocyanate concentrations in serum and urine of cancer patients after
i.v. (4.5 g/m2) and oral (500 mg tablet three times daily) administration of amygdalin over a period
of 21 days. After i.v. administration, high concentrations of amygdalin (up to 1,400 lg/mL) but no
increase in the levels of cyanide or thiocyanate were observed in the blood serum. After oral
administration, amygdalin levels were much lower (< 0.5 lg/mL) compared to i.v. administration.
Cyanide was detectable in blood only after oral administration (2.1 lg/mL). Excretion rates were not
determined. These ﬁndings suggest that human tissues are unable to hydrolyse amygdalin
distributed in the blood after i.v. infusion. Further, absorption of amygdalin from the gastrointestinal
tract appears to be marginal, but extensive degradation to cyanide occurs in the gut by the
microﬂora.
In support of the capability of the human faecal ﬂora to degrade amygdalin to cyanide, the release
of cyanide was observed when several common human faecal bacteria were incubated with amygdalin
in vitro. The highest activity was observed for Bacteroides fragilis, a constituent of human faecal
microﬂora (Newton et al., 1981).
In a healthy human volunteer ingesting 3, 6 or 12 mg of KCN, maximum blood levels of cyanide
were reached after 10–20 min and amounted to 1, 6 and 21 lM; the elimination half-life in blood was
about 20 min (Schulz, 1984). In other studies on humans, half-lives of 0.34–1.0 h have been reported
(Ansell and Lewis, 1970; Hartung, 1982).
Because of the high binding of cyanide to methaemoglobin in erythrocytes, the volume of distribution
of cyanide depends on the methaemoglobin content of the blood and also on the total concentration of
cyanide in the body (Schulz et al., 1982). As 1 g of methaemoglobin can bind approximately 60 lM of
cyanide (Schulz, 1984), 1 L of blood with a normal physiological methaemoglobin level of 0.25 to 1% is
able to bind 25–100 lM of cyanide. The volume of distribution of low doses of cyanide in humans has
been estimated as approximately 0.075 L/kg (Schulz et al., 1982).
In contrast to cyanide, the major metabolite thiocyanate does not bind to methaemoglobin in blood
and is not readily distributed into tissues but excreted in the urine. The apparent distribution volume of
thiocyanate in healthy humans has a mean value of 0.25 L/kg and the half-life in blood serum ranges
from 1.5 to 5 days (Schulz et al., 1979).
Abraham et al. (2016) studied the bioavailability of cyanide from foods (persipan in two different
amounts, linseed, cassava or bitter apricot kernels) containing various CNGs in a ﬁve-way crossover
study with at least 2 weeks between the different arms of the study. Each of 12 healthy non-
smoking adults (aged 30–56 years, ﬁve females with a mean body weight of 64.6 kg and seven
males with a mean body weight of 81.0 kg) ingested six medium-sized kernels (about 2.1 g,
containing 6.8 mg total cyanide). The aim was for ‘worst case conditions’, which involved an
overnight fast before the study, thorough chewing to facilitate maximal release of free cyanide from
the glycosides, and consumption of 200 mL tap water after consumption and again after 60 min but
no other food or water until the end of the investigation. The blood cyanide levels were determined
thereafter using a GC-MS method with K13C15N as internal standard. The maximum blood level was
observed 20 min after ingestion of the apricot kernels and amounted to a mean value of
15.46 lM15 (range 7–23), followed by a steep decrease. The dose of 6.8 mg total cyanide was
selected in order to result in maximum blood cyanide levels in the region of 20 lM, a level that was
considered to be safe. The mean cyanide doses corresponded to 0.105 mg/kg bw in women and
0.084 mg/kg bw in men, and the peak blood cyanide levels following consumption of apricot kernels
(mean  SD, Standard Deviation) were 20.06  3.35 lM in women and 12.17  3.19 lM in men.
These levels did not differ statistically signiﬁcantly from those of the cassava study, in which the
mean peak blood cyanide concentrations were 21.30  6.28 lM in women and 13.84  3.44 lM in
men. The differences were found to be correlated with body weight and sex, but not with age.
When one of the test persons ingested bitter apricot kernels, KCN or pure amygdalin alone or
together with sweet almonds (to provide the hydrolytic plant enzymes) in amounts equivalent to
6.8 mg cyanide, the peak levels of cyanide in whole blood were 15.4, 20.1, 3.4 and 10.0 lM
(Abraham et al., 2016). This suggests that the cyanide present in the apricot kernels is almost
15 A value of 14.3 µM is cited in the text while the value of 15.46 µM is reported in Table 1 of Abraham et al. (2016).
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completely bioavailable, while cyanide present in pure amygdalin is only partly released upon
ingestion in the absence of the hydrolytic plant enzymes.
3.1.1.3. Biomarkers
Cyanide in blood is frequently used as an exposure biomarker for cyanide poisoning. Methods
applied include colorimetric reaction followed by spectrophotometric detection as well as high
performance liquid chromatography with mass spectrometry (HPLC-MS), gas chromatography-
microwave-induced plasma atomic emission detection (GC-MPD), gas chromatography-electronic
capture detection (GC-ECD) and gas chromatrography-mass spectrometry (GC-MS) (summarised in
ATSDR, 2006). In the literature, there are different opinions concerning the biomaterial (whole
blood, erythrocytes or plasma) to be preferred for this purpose. In blood, cyanide is almost
exclusively localised in erythrocytes and only a relative small proportion is transported via plasma.
In the literature, erythrocyte to plasma ratios of at least 10:1 are frequently cited Rumack, 1983).
These ratios were also conﬁrmed by Lundquist et al. (1985). In this study, cyanide concentrations in
whole blood, plasma and erythrocytes were compared in 10 non-smoking subjects and ﬁve smoking
subjects. For the non-smokers, the mean cyanide values ( SD) were 0.13  0.08 lM for whole
blood, 0.24  0.22 lM for erythrocytes and 0.02  0.02 lM for plasma; for the smokers, the mean
cyanide values ( SD) were 0.33  0.12 lM for whole blood, 0.68  0.20 lM for erythrocytes and
0.03  0.02 lM for plasma. Thus, some authors recommend cyanide analysis in erythrocytes
(McMillan and Svoboda, 1982; Sano et al., 1992) or in whole blood (summarised in Lundquist et al.,
1985; ATSDR, 2006). Other authors state that quantifying cyanide in whole blood results in falsely
high results caused by an artefactual formation of cyanide from plasma thiocyanate and
oxyhaemoglobin. Furthermore, it has to be taken into account that HCN is a very weak acid and
thus cyanide exists in the blood almost entirely as HCN, whose half-life in blood is less than 1 h.
Therefore, all steps of storage, sample preparation and the analytic process itself have to be carried
out with caution to minimise the risk of cyanide loss and falsely low levels.
In contrast to cyanide, its stable metabolite thiocyanate is conﬁned to plasma. Therefore, some
studies determined thiocyanate in serum or plasma as a measure of cyanide exposure. More
recently, in addition to cyanide, ATCA (see Figure 4 Section 3.1.1.1) in plasma has been used as a
potential biomarker (Lundquist et al., 1995; Logue, 2005, 2009; Vinnakota et al., 2012).
Additionally, cyanide adducts with human serum albumin have been discussed recently from an
analytical point of view to be a more stable and thus reliable biomarker for cyanide exposure as
compared to cyanide in whole blood (Fasco et al., 2007, 2011). The CONTAM Panel is aware of
other potential biomarkers for cyanide poisoning including thiocyanate in urine. Additionally,
potential effect biomarkers have been identiﬁed in animal studies. As this assessment was conﬁned
to the exposure biomarker cyanide in blood, other potential biomarkers are not described here in
detail.
3.1.2. Toxicity studies
3.1.2.1. Toxicity in laboratory animals
The overt clinical effects in experimental animals due to lethal levels of cyanide exposure are:
dyspnoea, irregular shallow and gasping breathing, ataxia, tremors, retrocolic spasms, tonic spasms,
loss of consciousness, convulsions and asphyxiation. Brain seems to be the organ most sensitive to
acute cyanide toxicity. DECOS (2002) note that these effects occur irrespective of the route of
exposure. They refer to the following studies: Ballantyne (1983, 1994); US EPA (1992); ATSDR (1997).
Furthermore, the cyanide ion being the common agent that induces tissue anoxia by inhibiting tissue
cytochrome oxidase activity in different species, there are no qualitative differences in acute toxicity
between cyanide compounds (Way, 1984; US EPA, 1988; WHO, 2004).
Acute toxicity of cyanides
Acute oral LD50 values for cyanide reported in previous assessments (WHO, 1965; DECOS, 2002;
ATSDR, 2006) ranged from 2.13 to 6 mg/kg bw (see Table 1).
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Short-term toxicity of cyanides
Kreutler et al. (1978) (reviewed by US EPA, 2010). Experimental design: Two-week toxicity study,
male weanling albino rats fed diets containing either low protein (2% casein) or normal protein (20%
casein) and supplemented with 0.2% (2 g KCN/kg). Evaluations: Body and thyroid weight and plasma
thyroid stimulating hormone (TSH). Negative results: No difference in body weight among cyanide and
respective control group, no effect on serum TSH or thyroid weight was observed in rats subjected to
KCN in a normal-protein diet. Effects of KCN: Increase in thyroid weight and TSH serum levels in rats
subjected to KCN in a low-protein diet.
Tulsawani et al. (2005). Experimental design: Female Wistar rats dosed by gavage to 7 mg KCN/kg
bw once daily for 14 days. Evaluations: Organ-body index, haematological, clinical chemical and urine
analyses, histopathological examination. Negative results: Although this dose falls in the LD50 range
identiﬁed for KCN (see Table 1), the authors failed to detect any mortality in the treatment group. As
KCN solutions were prepared freshly and administered by gavage, instability of cyanide concentration
in solution and/or detoxiﬁcation mechanisms does not provide reasons for these results. No signiﬁcant
changes in body weight and organ-body index. Effects and altered biomarkers due to KCN: Increased
serum thiocyanate and blood glucose, decreased alanine aminotransferase (ALT). Signiﬁcant inhibition
of cytochrome c activity, signs of lipid peroxidation and impairment of antioxidant defence speciﬁcally
in the brain, as well as demyelination in medulla oblongata, chromatolysis and degeneration of
cerebrocortical cells. Fatty changes of various grades and vacuolar degeneration of hepatocytes,
varying in size and more pronounced in the central region, coupled to eosinophilic debris. Hepatic
rhodanese activity was also signiﬁcantly decreased. In addition, focal myocardial degeneration
glomerular congestion, tubular lesions displaying vacuolar degeneration at proximal tubular epithelial
cells and scattered tubule disorganisation due to damaged renal parenchyma were also observed.
Sousa et al. (2002) (reviewed by US EPA 2010). Experimental design: Fifteen-day toxicity study,
male adult Wistar rats treated with KCN in drinking water adjusting KCN concentration to body weight
and water consumption in order to administer 0, 0.3, 0.9, 3.0 or 9.0 mg/kg per day. Evaluation:
Haematological, biochemical (in serum) and urine analyses, histopathology. Negative results:
Biochemical and urine analysis revealed no or only sporadic changes which were not dose related.
Effects and altered biomarkers due to KCN: Increased plasma thiocyanate levels in all experimental
groups. ‘Moderate’ to ‘severe’ congestion and cytoplasmic vacuolisation of the epithelial cells of the
kidney proximal tubules at 3.0 or 9.0 mg/kg per day (both severe), hydropic degeneration of
hepatocytes at 9.0 mg/kg per day (severe), resorption vacuoles in the thyroid gland of animals in all
groups, including controls (minimal), which increased in severity up to 0.9 mg/kg day (severe). Lowest
observed adverse effect level (LOAEL)–No observed adverse effect level (NOAEL): Although resorption
vacuoles in the thyroid gland were reported as moderate at 0.3 mg KCN/kg (0.12 mg/kg CN) and
severe at 0.9 mg KCN/kg, based on moderate kidney vacuolisation and congestion, the US EPA (2010)
Table 1: Summary of acute toxicity studies with cyanides after oral exposure(a)
Compound Species LD50 (mg/kg bw) LD50 (mg CN
−/kg bw) References
HCN Rabbit 2.49 2.39 DECOS (2002), Ballantyne (1987)
Rat 4.21 4.05 DECOS (2002), Ballantyne (1987)
NaCN Rabbit 5.11 2.71 DECOS (2002), Ballantyne (1987)
Rat 5.72 3.04 DECOS (2002), Ballantyne (1987)
Rat 8 4.2 ATSDR (2006), Smyth et al. (1969)
KCN Rat 10–15 4.02–6.03 WHO (1965), Conn (1979)
Rat 7.48 2.99 DECOS (2002), Ballantyne (1987)
Mouse 8.50 3.4 DECOS (2002), Ballantyne (1987)
Mouse 15.8 6 WHO (2004), Ferguson (1962)
Rabbit 5.82 2.33 DECOS (2002), Ballantyne (1987)
Dog 5.3 2.13 WHO (1965), Conn (1979)
Ca(CN)2 Rat 22 3.49 ATSDR (2006), Smyth et al. (1969)
bw: body weight; HCN: hydrocyanic acid; HPLC-DAD: high performance liquid chromatography with diode-array detectionl; LD50:
medium lethal dose.
(a): Medium lethal oral doses (LD50) for cyanides obtained from previous assessments (WHO, 1965; DECOS, 2002; ATSDR, 2006)
and based respectively on the works of Conn (1979), Ballantyne (1987) and Smyth et al. (1969).
Cyanogenic glycosides in apricot kernels
www.efsa.europa.eu/efsajournal 22 EFSA Journal 2016;14(4):4424
identiﬁed a NOAEL of 0.9 mg KCN/kg per day (0.36 mg/kg CN) and a LOAEL of 3 mg/kg per day
(1.2 mg/kg CN) from this study.
Palmer and Olson (1979) US EPA (2010). Experimental design: Male Sprague-Dawley rats treated
with KCN 200 mg/L in drinking water or food for 21 days. Evaluations: Body and liver weight. Effects
due to KCN: A statistically signiﬁcant 17% increase in absolute liver weight. The dietary part of this
study has been considered inconsistent due to the instability of cyanide in food.
EFSA (2004) (based on the revision of original data by Leuschner and Neumann, 1989; NOAEL and
LOAEL not provided). Experimental design: Thirteen-week toxicity study, male Sprague-Dawley rats
administered KCN in the drinking water (40, 80 and 160/140 mg KCN/kg bw per day). Evaluation:
Behaviour, external appearance, body weight, haematological, clinical chemical (in serum) and urine
analyses, histopathological examination (brain, kidneys, heart, liver and testes plus thyroid in the high-
dose group (160/140 mg) KCN/kg because of observed reduced body weight gain, reduced water
consumption and mortality). Negative results: No histopathological damage. Decreased body weight
and food consumption in KCN rats caused by a decrease in water consumption due to a decreased
palatability. Effects due to KCN: Dose-related higher levels of protein in urine in KCN group compared
to controls. Rats treated with 40 and 80 mg/kg bw KCN exhibited a slight increase in relative organ
weight, which became clearly increased at 160 and 140 mg/kg while thymus weight was reduced in
the high-dose group. No histopathological damage. Decreased body weight and food consumption in
KCN rats caused by a decrease in water consumption due to a decreased palatability.
NTP (1993) (reviewed by US EPA, 2010). Experimental design: Thirteen-week study, male and
female F344/N rats and B6C3F1 mice received 0, 3, 10, 30, 100 or 300 mg NaCN/L per day in drinking
water. The average exposures were 0, 0.3, 0.9, 2.7, 8.5 and 23.6 mg NaCN/kg bw per day in male
rats and 0, 0.3, 1.0, 3.2, 9.2 and 23.5 mg NaCN/kg bw per day in female rats. Average exposures in
mice were 0.5, 1.8, 5.1, 16.2 and 45.9 mg NaCN/kg bw per day in males and 0.6, 2.1, 6.2, 19.1 and
54.3 mg NaCN/kg bw per day in females, respectively. Evaluation: Behaviour, external appearance,
body weight, haematological, clinical chemical (in serum) and urine analyses, histopathological
examination (complete), sperm motility and vaginal cytology. Negative results: No deaths, clinically
signiﬁcant body weight-, histopathologic-, or clinical pathology changes were evident in both sexes of
either species. Haematological, clinical chemistry and urinalysis evaluations of rats and mice revealed
minimal changes that were considered not biologically signiﬁcant. Effects and altered biomarkers due
to NaCN: reduced water consumption (10–30%) in rats and mice in the 100 and 300 mg NaCN/L per
day groups. Urine thiocyanate (monitored only in male rats) increasing with dose starting from 10 mg
NaCN/L (0.9 mg NaCN/kg bw per day). Adverse effects on rat reproductive system observed were a
slight dose-dependent reduction in cauda epididymal weight in all groups of exposed male rats (only
rats exposed to ≥ 30 mg/L NaCN were considered) and reduced number of spermatid heads per testis
at 300 mg NaCN/L. In male mice, relative weights of the epididymis and cauda epididymis were
signiﬁcantly decreased at 100 mg NaCN/L (16 mg NaCN/kg bw per day) (US EPA, 2010).
Concentrations of 100 and 300 mg NaCN/L caused a signiﬁcant increase in length of pro-oestrus and
dioestrus relative to oestrus and metoestrus in female rats. LOAEL: Based on signiﬁcantly decreased
cauda epididymis weights, US EPA (2010) calculated a LOAEL of 30 mg NaCN/L per day (2.7 mg
NaCN/kg per day; 1.44 mg/kg CN) in rats and of 100 mg/L (16 mg NaCN/kg bw per day; 8.51 mg/kg
CN) in mice.
Philbrick et al. (1979). Experimental design: Eleven-month toxicity study, ﬁrst evaluation at
4 months, 1,500 KCN mg/kg feed in male weanling rats (average weight 43 g) fed two different diets
containing 10% casein with different supplementation with DL-methionine, potassium iodide and
vitamin B12 for 11 months. Evaluations: Behaviour, external appearance, body weight, plasma
thyroxine, thyroxine secretion rates and urinary thiocyanate. Negative results: No death or clinical
signs. Effects due to KCN: Body weight signiﬁcantly lower starting from 8 weeks of treatment, plasma
thyroxine and thyroxine secretion rate signiﬁcantly reduced at 4 months of treatment irrespective of
diet, suggesting depressed thyroid gland functions.
Conclusions on acute and short-term toxicity studies with cyanides
The acute oral LD50 values for cyanide range from 2.13 to 6 mg/kg bw. The NTP (1993) 13-week
study provided a LOAEL of 2.7 mg NaCN/kg bw per day (1.44 mg/kg CN) in rats and of 16 mg
NaCN/kg bw per day (8.51 mg/kg CN) in mice, based on decreased cauda epididymis weights. The
LOAEL derived in rats was conﬁrmed by a 15-day study (1.2 mg/kg CN) by Sousa et al. (2002),
which also provided a NOAEL of 0.9 mg KCN/kg bw per day (0.36 mg/kg CN) based on histological
changes in the kidneys. In general, histopathological changes were observed after 2 weeks of
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repeated exposure to cyanide, but were absent in sub-chronic studies where organs weights were the
parameters most frequently affected in adult rodents. No clinical signs were observed in short-term
studies and changes in haematology and urine were minor, sporadic and not dose related. In none of
the reported short-term studies was mortality observed at doses up to 40 mg CN/kg bw per day,
even though some of the doses were equal to or higher than the oral LD50 for cyanide. Since in the
short-term studies analysed, cyanide was administered through the diet or drinking water, absence of
mortality is possibly due to a slower absorption rate following dietary exposure, thus not exhausting
the detoxiﬁcation capacity of the enzyme rhodanese, which occurs after bolus administration in LD50
tests (Hayes, 1967; US EPA, 2010).
Acute and short-term toxicity of amygdalin
Acute toxicity of amygdalin
Toxicity of CNGs depends on HCN release by hydrolysis of gut microbiota and subsequent
absorption. Accordingly, a single oral dose of 600 mg amygdalin (35.4 mg HCN per kg bw) induced
blood cyanide increases (2.6–4.5 lg/mL) and mortality in conventional but not germfree rats of the
same strain (Carter et al., 1980; FAO/WHO, 2012). The estimated LD50 for the amygdalin in rats
ranges from 522 mg (30.8 mg HCN) to 880 mg (51.9 mg HCN)/kg bw (Adewusi and Oke, 1985;
Newton et al., 1985). This lower acute toxicity as compared to HCN is explained by the slow and
incomplete release of HCN from CNGs (EFSA, 2004).
Short-term toxicity of amygdalin
Oyewole and Olayinka (2009). Experimental design: Fourteen-day toxicity study, 20 mg amygdalin/kg
bw (equivalent to 1.18 mg HCN; obtained from Sigma16) orally administered by cannula to male Wistar
rats daily. Evaluations: Haematological and serum analysis, histological examination of the liver. Effects
and altered biomarkers due to amygdalin: Mortality (one out of eight rats, 12.5%), signiﬁcant increase in
blood cyanide (15.23  1.22 lmol/L), haemoglobin concentration, packed cell volume and serum
lactate and a decrease in whole blood pH.
Basu (1983) (reviewed by EFSA, 2004). Experimental design: Twenty-four day toxicity study, guinea
pigs (Duncan-Hartley) received daily 10 mg laetrile (amygdalin, obtained from Sigma15; equivalent to
0.59 mg HCN) dissolved in 10% sucrose solution with and without ascorbic acid (100 mg). Negative
results: Administration of laetrile without or with ascorbic acid had no signiﬁcant effect on body and
liver weight. Alterations of biomarkers due to amygdalin: Treatment with laetrile alone for 4, 16 and
24 days resulted in a signiﬁcant increase in urinary levels of thiocyanate.
Conclusions on acute and short-term toxicity of amygdalin
The available data do not allow identiﬁcation of NOAELs and LOAELs.
Developmental studies with cyanide and amygdalin
de Sousa (2007). Experimental design: Pregnant rats received KCN at different concentrations in
drinking water, from gestation day (GD) 6 to GD 20, to obtain the target doses of 1.0, 3.0 and
30.0 mg/kg bw per day of KCN. Evaluations: Biochemical analyses and histopathology in the dams (GD
20 and at weaning) and litter at postnatal day (PND)21 plus examination for developmental
malformations in foetuses GD 20. Negative results: No death; body weight, reproductive data and
skeletal variation were unaffected. Effects due to KCN: Treatment resulted in a signiﬁcant and dose-
dependent increase in serum levels of thiocyanate only in dams sacriﬁced at GD 20. A signiﬁcant
increase in serum glucose levels was also evident, but only at 30 mg/kg per day KCN. Hepatic and
central nervous system congestion and gliosis were moderate in both dams and litter at postnatal day
(PND)21 at the highest dose of 30 mg KCN/kg per day. A dose-dependent increase in the number of
resorption vacuoles at the thyroid occurred in dams: mild for 1, moderate for 3 and severe for 30 mg
KCN/kg per day. As this effect is not associated with alteration to cholesterol levels (a parameter
indicative of thyroid functions), the authors concluded that the altered thyroid histology is a reﬂection
of the compensatory increase in the efﬁcacy of thyroid hormone synthesis. A NOAEL of 3 mg KCN/kg
(1.2 mg/kg CN) and LOAEL of 30 mg KCN/kg (12 mg/kg CN) were derived on the basis of
histological alterations both in dams and PND 21 litters.
16 Sigma uses the term laetrile as a synonym for amygdalin which is not correct.
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Willhite (1982). Experimental design: Female Golden Syrian hamsters (strain LVG) were treated by
gavage with a single dose of D,L-amygdalin (200, 225, 250 and 275 mg/kg bw or D-amygdalin
(300 mg/kg bw) obtained from the Division of Cancer Prevention, National Cancer Institute,
Bethesda, Maryland17) on GD 8. Evaluations: Examination for developmental malformations in
foetuses at GD 14. Effects due to amygdalin: Hyperpnoea, dyspnoea, ataxia and tremors occur
in mothers exposed to ≥ 250 mg/kg bw (equivalent to 14.2 mg CN/kg bw). The oral dose of
300 mg D-amygdalin/kg caused identical malformations at similar incidences. One mother exposed to
D,L-amygdalin 275 mg/kg and two mothers exposed to D-amygdalin 300 mg/kg died. Percentages of
abnormal foetuses progressively increase with the dose. In particular, exencephaly, encephalocoele
and skeletal malformations resulted at doses of ≥ 250 mg/kg bw (≥ 14.2 mg CN/kg bw). At 200 mg
D,L-amygdalin/kg bw (11.3 mg CN/kg bw), fused ribs were observed in two offspring of one mother
(maternal toxicity not reported). A supplementary group was treated with 300 mg D-amygdalin/kg. No
teratogenic effects were noted when hamsters received D,L-amygdalin [275 mg/kg bw (15.5 mg CN/kg
bw)] intravenously. The teratogenic effects found were considered to be due to cyanide released by
bacterial b-glucosidase in the gastrointestinal tract.
A NOAEL of 225 mg D,L-amygdalin/kg bw (12.8 mg CN/kg bw) and a LOAEL of 250 mg
D,L-amygdalin/kg bw (14.2 mg CN/kg bw) is derived on the basis of foetal abnormalities.
Conclusions on developmental studies with cyanide and amygdalin
Indications of teratogenicity in offspring of hamsters treated with ≥ 250 mg/kg bw amygdalin
(equivalent to ≥ 14.2 mg CN/kg bw) on day 8 of gestation were observed in one study while signs of
toxicity were revealed both in rat dams and their weanling offspring after exposure to 30 mg KCN/kg
(12 mg CN/kg). A NOAEL of 225 mg D,L-amygdalin/kg bw (12.8 mg CN/kg bw) and a LOAEL of
250 mg D,L-amygdalin/kg bw (14.2 mg CN/kg bw) can be derived based on foetal abnormalities. A
NOAEL of 3 mg KCN/kg (1.2 mg/kg CN) and LOAEL of 30 mg KCN/kg (12 mg/kg CN) can be
derived based on histological alterations both in the dams and PND 21 litters.
3.1.2.2. Humans
The clinical signs of cyanide toxicity include headache, dizziness, mental confusion, stupor, cyanosis
with twitching and convulsions, followed by terminal coma. The EFSA AFC Panel noted that the human
acute lethal oral dose of HCN is reported to be 0.5–3.5 mg/kg bw. Cyanogenic glycosides are
hydrolysed by the gut microﬂora to slowly and incompletely release cyanide with subsequent
absorption and therefore the acute toxicity for CNGs would be lower than that of HCN. Well-nourished
individuals have ingested 1,000 mg (equivalent to 59 mg HCN) or more of pure amygdalin every day
without any evidence of ‘side effects’ (EFSA, 2004).
It is frequently cited that the toxicity threshold for cyanide in whole blood is about 20 lM. This
originates mainly from Rumack (1983) who summarised blood cyanide concentrations and associated
symptoms, although noting that they were ‘very questionable’. The ranges were no signs of toxicity
at blood cyanide concentrations of 0.2–0.5 mg/L (8–20 lM); ﬂushing and tachycardia occur at
0.5–1.0 mg/L (20–38 lM), a reduced level of consciousness (obtunded) at 1.0–2.5 mg/L (48–95 lM),
coma at 2.5–3.0 mg/L (95–114 lM) and death at 3.0 mg/L (114 lM). Rumack (1983) noted that a
very wide range of lethal concentrations had been reported (0.1–230 mg/L; 4–8,570 lM), and that in
many cases blood was sampled at autopsy without taking into account the time since exposure. In
addition, cyanide concentrations decrease in stored blood, which could further contribute to falsely low
values being reported (Hall and Rumack, 1986). The basis for the ranges cited by Rumack, and
whether they incorporated some form of extrapolation to allow for the rapid elimination of cyanide, is
unclear. Furthermore, no information is available on the extent to which these ranges cover the full
range of possible variability in sensitivity to cyanide within different subgroups, such as children. Some
support for assuming the threshold of 20 lM comes from Schulz et al. (1982), who reported that,
based on a review of the literature, biochemically detectable disturbances occur at erythrocyte cyanide
concentrations above 40 lM, clinically recognisable symptoms above 200 lM and possible fatalities
above 400 lM. As the ratio of cyanide concentrations in erythrocytes to that in plasma is at least 10:1
(Rumack, 1983), Abraham et al. (2016) concluded that the concentration of 200 lM in erythrocytes
approximately corresponds to 20 lM in whole blood. However, the CONTAM Panel noted that there is
uncertainty in the applied (10:1) erythrocyte to plasma ratio of cyanide. Some of the evidence for the
toxicity threshold of 20 lM derives from clinical studies. For example, Aitken et al. (1977) monitored
17 Amygdalin is present in apricot kernels as the D-stereoisomer and not as a mixture of the D and L forms.
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eight female and ﬁve male patients (aged 13–66) receiving the hypotensive agent sodium nitroprusside
(which contains 44% cyanide) undergoing surgery for repair of an intracranial aneurysm. They found
that blood cyanide levels above 0.53 mg/L (20 lM) were associated with proportionately greater
degrees of metabolic acidosis.
The AFC opinion summarised a number of case reports of human poisoning associated with ingestion of
amygdalin preparations or apricot kernels.18 For amygdalin preparations, these included a 11-month-old
girl who ‘accidentally’ ingested –one to ﬁve amygdalin tablets (500 mg, equivalent to 28.5 mg CN),
and a 17-year-old girl suffering from cancer who regularly took four ampoules of laetrile (3 g
amygdalin, equivalent to 171 mg CN) intravenously who became ill after swallowing orally the content
of 3.5 ampoules of laetrile. For apricot kernels, these included nine cases of cyanide intoxication of
children who had probably ingested more than 10 wild apricot kernels (208 mg CN/100 g).
The CONTAM Panel identiﬁed two additional case reports with information on the number of
kernels consumed that were published before 2004 and not included in the AFC Panel opinion, but
were cited in other risk assessments. A 49-year-old female was hospitalised following the consumption
of 20–40 apricot kernels (Rubino and Davidoff, 1979a,b). The authors considered that this amount
would have been lethal had the woman not vomited substantial quantities of chewed kernels. A
41-year-old woman was found in a comatose and hypothermic state following the consumption
of approximately 30 bitter apricot kernels and recovered following administration of a cyanide
antidote. Her blood cyanide level was 43.1 lM (1.16 mg/L) 5 h after ingesting the kernels (Suchard
et al., 1998).
Since the AFC opinion of 2004, a number of additional case reports have been published.
Amygdalin and amygdalin-containing herbal preparations
A 68-year-old woman with carcinoma of the bladder began to feel ill about 30 min after taking six
500 mg amygdalin tablets (reported to correspond to 100 mg of cyanide) and presented at hospital
about 2 h later with signs of cyanide toxicity. An antidote was administered and she made a full
recovery. The authors noted that the severity of her reaction was not expected from the amygdalin
alone and postulated that the effects of cyanide were exacerbated by coingestion of megadoses of
vitamin C (4,800 mg) (Bromley et al., 2005).
A 51-year-old woman with a history of breast cancer developed symptoms of cyanide toxicity after
inadvertently taking ﬁve 500 mg laetrile tablets and recovered following administration of a cyanide
antidote (Martinelli et al., 2008).
A 63-year-old woman with a history of metastatic carcinoma of the lung was diagnosed with
cyanide poisoning. She had been taking a herbal product containing amygdalin extract (500 mg) over
5 months. Her blood cyanide concentration was 4.38 mg/L (162 lM). She recovered after antidote
treatment (Lam et al., 2012).
A 4-year-old boy with a history of malignant brain disease was diagnosed with cyanide poisoning.
He had been given a number of complementary medicines, including a preparation referred to as
‘vitamin B17’ (4 9 500 mg/day) and apricot kernels (5–10/day). His serum cyanide level was 0.5 mg/L
(18.5 lM) 2 h after the last administration of the ‘vitamin B17’ preparation. He recovered after
administration of a cyanide antidote (Sauer et al., 2015). The CONTAM Panel noted that the
concentration has been measured in serum and that the corresponding concentration in whole blood
level would have been an order of magnitude higher (see also Section 3.1.1).
Apricot kernels
There are a number of reports of cyanide toxicity in children who have ingested apricot kernels
(sometimes referred to as apricot seeds in the individual reports). According to National Poison Centre
data, there were 260 cases of paediatric apricot kernel poisoning in Turkey during 2000–2004 (Oto
Gecim et al., 2006; cited by Akyildiz et al., 2010). Akyildiz et al. (2010) reviewed admissions of children
to a hospital in Turkey with signs of cyanide toxicity following ingestion of apricot kernels. Thirteen
children aged 3–9 years (four male, nine female) were admitted between 2005 and 2009. The median
(range) of apricot kernels consumed was 8 (5–21). All patients recovered following treatment.
A 28-month-old girl suffered severe cyanide toxicity after eating approximately 10 apricot kernels,
and died 22 days later despite antidote treatment. Her blood cyanide level was more than 3 mg/L
(110 lM) 20 h after arrival at the emergency department (Sahin, 2011).
18 Apricot kernels are sometimes referred to as apricot seeds in the individual reports, but the term kernels is used in this
opinion.
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A previously healthy boy aged 27 months (11 kg) was diagnosed with cyanide toxicity after eating
‘plenty of apricot pits’ and recovered after treatment (Kaya et al., 2012).
A 58-year-old man with metastatic colon carcinoma was found to have elevated serum liver
enzymes when reporting to hospital for chemotherapy. He had been taking 70 apricot kernels
(chopped thoroughly) per day for 45 days up to a week before the outpatient visit. He did not have
any of the common side effects of amygdalin use, and no lactic acidosis. A blood thiocyanate level of
71 mg/L was measured, which the authors back-extrapolated to a concentration of 118 mg/L on the
last day of apricot kernel consumption (Seghers et al., 2013).
Almıs et al. (2014) reviewed admissions to a paediatric emergency service in Turkey due to plant
poisoning between January 2010 and May 2012. Five of the 23 cases were associated with
consumption of apricot kernels, but no further detail is available on these patients.
In the bioavailability study of Abraham et al. (2016), described in Section 3.1.4, the dose level was
selected in order to result in maximum blood cyanide levels in the region of 20 lM, because this was
considered to be a safe level citing Rumack (1983) and Schulz et al. (1982). The average doses
corresponded to 0.105 mg/kg bw in the women and 0.084 mg/kg bw in men. The volunteers did not
report any symptoms of cyanide toxicity; however, clinical parameters such as blood lactic acid were
not measured. The highest blood level of 31.9 lM was found in the woman with the lowest body
weight (60 kg) when she consumed cassava: the cyanide dose was equivalent to 0.113 mg/kg bw. In
a separate study, one of the 12 volunteers, an 80-kg male, consumed persipan paste in amounts
corresponding to 6.8, 13.6 and 27.2 mg cyanide (equivalent to 0.085, 0.17 and 0.34 mg/kg bw). Again
he did not report symptoms of cyanide toxicity; however, his maximum blood cyanide level did not
exceed 20 lM.
In conclusion, cases of acute cyanide toxicity have resulted from ingestion of amygdalin
preparations and of bitter apricot kernels, and some of these cases were fatal. For adults, the number
of kernels consumed was 20 or more. For children ﬁve or more kernels appear to be toxic. In a
bioavailability study in a small number of healthy adults, the subjects did not report symptoms of
cyanide toxicity at total cyanide doses of up to 0.113 mg/kg bw in women and 0.34 mg/kg bw in men
(the highest doses tested), but there were no clinical measures of toxicity.
3.1.3. Mode of action for acute toxicity
The primary mode of action underlying acute toxicity of cyanide involves impairment of oxidative
phosphorylation, a process whereby oxygen is utilised for the production of essential cellular energy
sources in the form of adenosine triphosphate (ATP). An essential part of this process includes the
transfer of electrons from nicotinamide adenine dinucleotide (NADH), to oxygen through a series of
electron carriers. This is catalysed by the cytochrome oxidase enzyme system in mitochondria (Beasley
and Glass, 1998). Cyanide inhibits the terminal enzyme in this chain reaction, namely cytochrome
oxidase a3, which is necessary for the reduction of oxygen to water in the fourth complex of oxidative
phosphorylation (Hamel, 2011). More speciﬁcally, cyanide binds to ferric iron (Fe3+) in the haem
moiety of the oxidised form of cytochrome oxidase a3 to suppress its oxidative function and thereby to
block cells from using oxygen, which is the substrate of normal cellular respiration (Hall and Rumack,
1986; Beasley and Glass, 1998; Guidotti, 2006; Hamel, 2011; Sahin, 2011). Consequently, tissue
utilisation of oxygen is inhibited with rapid cessation of aerobic metabolism and impairment of vital
functions. Other metabolic processes continue and the rate of glycolysis markedly increased leading to
accumulation of intracellular NADH (Veech et al., 1970). Furthermore, produced pyruvate can no
longer be utilised via the impaired Krebs cycle and is reduced to lactate, resulting in a state of
metabolic acidosis (Beasley and Glass, 1998). Glucose is also partly converted by the pentose
phosphate pathway leading as well to an increase in lactic acid with a decrease in ATP/ adenosin
diphosphate (ADP) ratio (Way, 1984). Overall, cyanide causes cells to switch from an aerobic (oxygen-
dependent) metabolism mode that yields ATP to anaerobic (oxygen-independent) energy production,
which generates toxic
by-products, such as lactate (Hall and Rumack, 1986; Guidotti, 2006; Hamel, 2011; Sahin, 2011).
Characteristics features are thus hypoxia and acidosis.
The heart and brain are particularly prone to cyanide acute toxicity, because of their requirement
for a continuous supply of oxygen and ATP generated from aerobic metabolism (Guidotti, 2006). Poor
oxygen extraction associated with cessation of aerobic cellular respiration equally leads to an
accumulation of oxygen in the venous supply indicated by blood gas analysis and a reduced
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arteriovenous oxygen saturation difference. Some cyanide also binds to methaemoglobin, the ferric
form of haemoglobin, which accounts for normally 1–2% of all haemoglobin.
It should also be mentioned that cytochrome oxidase a3 is not the only enzyme negatively affected
by cyanide and that additional mechanisms may drive its acute toxicity (Beasley and Glass, 1998). In
this respect, cyanide inhibits about 40 enzymes, including a number of other important
metalloenzymes containing iron, copper or molybdenum ions, such as alkaline phosphatase, carbonic
anhydrase, catalase, peroxidase, ascorbic acid oxidase, xanthine oxidase and succinic dehydrogenase.
All these reactions may contribute to the toxicity proﬁle of cyanide as well (WHO, 2004) leading to
cellular signalling unbalance and the occurrence of centrally mediated symptoms (i.e. tremors), cardiac
and peripheral autonomic responses.
3.1.4. Derivation of an acute reference dose
Cyanide is released from CNGs (amygdalin) in apricot kernels during chewing and as a result of
metabolism in the gastrointestinal tract. This process has resulted in cases of cyanide poisoning,
including fatalities following ingestion of apricot kernels. Therefore, the CONTAM Panel concluded that
an ARfD should be established for cyanide in order to consider the acute health risks related to CNGs
in apricot kernels.
The oral LD50 of cyanide in various animal species is in the region of 2.13–6 mg CN
/kg bw. In
humans, an acute lethal dose of 0.5–3.9 mg/kg bw is reported. These data suggest that there is no
major difference in species sensitivity, but do not provide a suitable basis for derivation of an ARfD
because of the uncertainty regarding the steepness of the dose–response relationship and
extrapolation from the lethal dose to a NOAEL. The lowest NOAEL and LOAEL from the animal toxicity
data reviewed are 0.36 and 1.2 mg CN/kg bw, respectively, from a study in rats exposed to KCN in
their drinking water for 15 days. No mortalities were reported in repeat dose toxicity studies in rodents
at doses up to 40 mg/kg bw per day, even though some of the doses clearly exceeded the LD50. Most
of these studies involved administration of cyanide salts in drinking water, which would be consumed
throughout the day and night resulting in lower peak cyanide concentrations in blood than with bolus
administration. Thus these studies are of questionable relevance to the acute toxicity of cyanide.
Therefore, despite their limitations, the human data are the preferred basis for deriving an ARfD in
order to avoid the uncertainty in species extrapolation. The reports of cyanide poisoning following
ingestion of apricot kernels do not provide sufﬁcient information on the numbers of kernels consumed
and their CNG content, to allow estimation of cyanide exposure. The CONTAM Panel concluded that
the blood cyanide concentration of 20 lM, which is reported to be a threshold for toxicity (Rumack,
1983), should be extrapolated to an external dose of cyanide to provide the basis for the ARfD.
In the bioavailability study of Abraham et al. (2016), 12 healthy adult volunteers consumed CNGs,
corresponding to 6.8 mg total cyanide, from a number of different sources including bitter apricot
kernels and cassava. The amount of CNGs was selected with the aim of producing a peak blood
cyanide concentration of 20 lM in the volunteers as this was considered to be a safe level. The
highest blood level of 31.9 lM was found in the woman with the lowest body weight (60 kg), who
received the highest cyanide dose expressed on a body weight basis (0.113 mg/kg bw) when she
consumed cassava. This single dose was used by Abraham et al. (2016) in proposing an ARfD. The
CONTAM Panel noted that the peak blood cyanide concentration of this individual was much higher
than that of the other volunteers when she consumed cassava, but not when she consumed bitter
apricot kernels, and there was no explanation for this difference. Therefore, the CONTAM
Panel concluded that the mean data should be used in deriving the ARfD, rather than the data from
this individual. The mean cyanide dose was 0.105 mg/kg bw in the women, which resulted in a mean
peak blood concentration of approximately 20 lM following consumption of both bitter apricot kernels
and cassava. In men, the mean cyanide dose was 0.084 mg/kg bw and the mean peak blood cyanide
concentration was lower than 20 lM.
Abraham et al. (2016) noted that cyanide is distributed in the body to the extent of about 40% in
blood, which has a volume of about 0.090 L/kg bw. Using these assumptions, and assuming 100%
bioavailability of 6.8 mg cyanide from bitter apricot kernels and cassava, the peak blood concentration
would be 0.47 mg/L (17 lM). Considering that following consumption of apricot kernels and cassava in
the Abraham et al. (2016) study, the mean peak blood concentration was 20–21 lM in females and
12–14 lM in males, it appears that the bioavailability was lower in males than in females, and this is
not just due to the differences in body weight. Therefore, in order to be conservative, the CONTAM
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Panel concluded that the cyanide dose of 0.105 mg/kg bw resulting in the blood concentration of
about 20 lM in the females should be considered as a NOAEL and used as the basis for the ARfD.
An UF of 10 is commonly used in deriving a health-based guidance value from a NOAEL in a human
study, comprising equal subfactors of 3.16 for interindividual variation in toxicokinetics and
toxicodynamics (EFSA Scientiﬁc Committee, 2012). Assuming that CNGs are completely broken down
to cyanide, and that the cyanide is rapidly absorbed and 100% bioavailable, it is highly unlikely that
individual variability could lead to appreciably higher peak blood levels. Because of the very short time
to peak blood level, individual differences in metabolism (e.g. due to reduced activity of rhodanese),
could delay elimination, but are unlikely to have an impact on the peak level. The variations in peak
blood levels seen in the study from Abraham et al. (2016) were small. Women have a smaller
distribution volume of blood than men and children have a larger blood volume (per kg/bw) than
adults. Therefore, the CONTAM Panel concluded that a default factor of 3.16 was not required and
that a factor of 1.5 was sufﬁcient to cover any additional variability in toxicokinetics.
The CONTAM Panel noted the lack of information on whether potentially sensitive individuals (e.g.
children) were included in the database underpinning the assumption that a blood cyanide level of
20 lM is a toxicity threshold, and that the study of Abraham et al. (2016) was conducted in a small
number of healthy volunteers. The CONTAM Panel concluded that a toxicodynamic subfactor should be
applied, and in the absence of cyanide-speciﬁc data on individual sensitivity, adopted the default
subfactor of 3.16. Dividing the NOAEL of 0.105 mg/kg bw by the factors of 1.5 and 3.16, with rounding
to a single signiﬁcant ﬁgure, an ARfD for cyanide of 0.02 mg/kg bw (20 lg/kg bw) is established for use
in assessing the risks associated with the presence of CNGs in apricot kernels.
3.2. Consumption data
The promoted portion sizes as provided by 11 websites promoting the consumption of raw apricot
kernels ranged from 5 up to 10 kernels per day for the general population, while for cancer patients,
the promoted portion size reached 60 apricot kernels per day.
3.3. Previously reported occurrence data
The Panel noted that the amount of amygdalin, and therefore of cyanide (originating from
amygdalin) in apricot kernels, can vary widely. Bitter apricot cultivars are reported to contain
signiﬁcantly more amygdalin compared to the sweet cultivar (Karsavuran et al., 2014). Yildirim and
Askin (2010) found that the concentration of amygdalin in bitter kernels was higher than that in the
sweet cultivar, while Femenia et al. (1995) reported that sweet apricot kernels (without skin) do not
contain any amygdalin.
Other authors refer that signiﬁcant differences in the content of amygdalin, and consequently of
HCN, in apricot kernels are due to geographical and climate characteristics. Chaouali et al. (2013)
noted that a dry climate and intense sunlight promote cyanogenesis, and that differences in amygdalin
concentration may be also ascribable to different agricultural practices. Finally, it has been reported
that the content of amygdalin may also vary according to the age of the plant at harvest time:
amygdalin gradually increases during plant growth, reaching the highest concentrations at maturity
(Chaouali et al., 2013).
Most of the information available from the scientiﬁc literature is related to amygdalin content in
apricot kernels; thus, for the purpose of comparison, levels of HCN have been estimated by using the
conversion factor of 0.059 (as deﬁned by JECFA, see Section 1.3.3). Since, as stated earlier, HCN
exists in aqueous biological systems always in a mixture of its undissociated and dissociated forms, the
respective levels are named ‘cyanide concentration’ and are expressed in mg/g (Table 3).
Concentration data of cyanide (originating from amygdalin) in bitter or sweet apricot kernels obtained
from eight scientiﬁc studies are summarised in Table 2. Cyanide concentrations ranged from a
minimum of 0.5 to a maximum of 3.8 mg/g in apricot kernels described as bitter, while a range of
0–1.7 mg/g was identiﬁed for apricot kernels described as sweet. Mean kernel weights of 0.4–0.6 g
were reported in these studies. However, there is considerable variation in the weights of individual
kernels. Abraham et al. (2016) weighed all kernels (n = 1,334) in a 500-g pack of bitter apricot
kernels, which had a mean  SD of 0.37  0.1 g (median 0.36 g, range 0.12–0.84 g).
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The CONTAM Panel notes that there is substantial variation in cyanide content within kernels
described both as ‘sweet’ and as ‘bitter’. However, there appears to be no objective criteria to
discriminate between sweet and bitter kernels and the cyanide content in these groups overlaps.
Table 2: Cyanide concentration levels in apricot kernels reported in the literature and additional
information (methodology used, kernel characteristics when analysed and kernel weights)
Cultivar
Cyanide concentration (mg/g) Methodology used
to measure
amygdalin or HCN
in kernels
Kernels as
analysed
Mean
kernel
weight (g)
References
Mean Min Max
Reported as
bitter
– 2.7(a) 3.8(a) Acidic titration
method (AOAC,
1980)
Dry matter,
without skin
0.5 Femenia
et al. (1995)
– 1.5 1.7 Alkaline-titration
method (AOAC,
1995)
– – Gupta and
Sharma
(2009)
3.3(a) 2.6(b) 3.8(a) HPLC-DAD Dry matter – Yildirim and
Askin (2010)
0.8 0.5 1.2 Argentometric
method, according to
ISO 2164-1975
standard, relating to
the dosage of CNGs
in leguminous plants)
Dry matter – Chaouali
et al. (2013)
1.5(a) 0.8(a) 2.4(a) HPLC-DAD Dry matter – Karsavuran
et al. (2014)
0.8(a) – – HPLC-DAD Dry matter – Bolarinwa
et al. (2014)
– 1.2 2.8 Acid hydrolysis
method
With skin 0.6 FSANZ
(2014)– 0.05 0.4 Without
skin
3.2(c) – – Acid hydrolysis,
subsequent
distillation of
liberated HCN and
titration (iodide/silver
nitrate) (VDL-UFA,
1976)
– 0.4 Abraham
et al. (2016)
Reported as
sweet
0(a) 0(a) 0(a) Acidic titration
method (AOAC,
1980)(b)
Dry matter,
without skin
0.6 Femenia
et al. (1995)
0.5(a) 0.2(a) 1.7(a) HPLC-DAD Dry matter –(d) Yildirim and
Askin (2010)
0.01(a) < 0.001(a) 0.02(a) HPLC-DAD Dry matter –(d) Karsavuran
et al. (2014)
HCN: hydrocyanic acid; HPLC-DAD: high performance liquid chromatography with diode-array detection.
(a): Estimated from the concentration of amygdalin according to the JECFA conversion factor: 1 g of amygdalin yields 59 mg
HCN; the CONTAM Panel is aware of the fact that the molecular weights of CN and HCN are different and that the cyanide
in the apricot kernels is a mixture of both HCN and CN. Thus, depending on the ratio of HCN and CN, the actual cyanide
concentrations might vary slightly.
(b): Limit of detection and limit of quantiﬁcation not speciﬁed in the original article.
(c): Kernels selected for cyanide content within a speciﬁed range, and therefore not necessarily representative.
(d): Data not provided in the original article.
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3.4. Food processing
The Mintel Global New Products Database (GNPD),19 a worldwide market research ﬁrm database,
and websites were consulted in order to obtain information on the availability of apricot kernels and
products thereof on the European market. Several raw apricot kernel products intended for human
consumption have been identiﬁed. These include whole apricot kernels (with and without skin), apricot
kernel butter, apricot kernel powder, ground apricot kernel capsules, apricot kernel nut bars, apricot
kernel oil capsules and cold-pressed apricot kernel oil.
Only a few relevant investigations studying the amygdalin/cyanide content of processed raw apricot
kernels have been identiﬁed by the CONTAM Panel.
In general, processing of CNG-containing plant material such as crushing, grinding, grating,
soaking, fermenting and drying reduces cyanide toxicity either through loss of water-soluble glycosides
or production of cyanide by action of plant or microbial enzymes and consequent loss through
evaporation prior to consumption (Bolarinwa et al., 2014).
Tuncel et al. (1990) investigated the effects of grinding, soaking and cooking on the degradation of
amygdalin present in bitter apricot kernels. Their results indicate that endogenous b-glycosidase
activity results in a substantial degradation of amygdalin during grinding and subsequent soaking.
Glycosides degraded faster in ﬁner particles as compared to coarse ones. They reported that cooking
(at 35°C) leads to a substantial reduction of non-glycosidic cyanogens already after 5 min while
complete removal of the glycosidic fraction was not achieved even after 30 min.
Peeling also inﬂuences cyanide concentration in apricot kernels. A study of cyanide levels in apricot
kernels with and without skin found that the levels in apricot kernels with skin ranged from 1,240 to
2,820 mg/kg, whereas in those without skin the levels ranged from 49 to 440 mg/kg (FSANZ, 2014).
Higher levels of cyanide detected in apricot kernels with skin may indicate that amygdalin is
concentrated within the skin. The processing methods used to remove the skin may also contribute to
a reduction in cyanide concentrations (FSANZ, 2014).
However, taking into account that a cyanide concentration of up to 3,800 mg/kg has been reported
in apricot kernels without skin (Femenia et al., 1995), the CONTAM Panel concluded that the data
available were insufﬁcient to distinguish between the cyanide content of kernels with and without skin.
Grinding of kernels is likely to result in lower amygdalin concentrations due to its hydrolysis by
endogenous plant enzymes. The concentration of cyanide is expected to temporarily increase and will
subsequently decrease due to the volatility of HCN. However, this has not been quantiﬁed.
3.5. Exposure assessment
3.5.1. Previous acute exposure assessments
Apricot kernels are consumed by a very limited part of the population. Due to this, consumption of
apricot kernels is not recorded in food consumption databases, and if present, the number of persons
is likely to be too limited, and thus not representative, for use in an exposure assessment. Also, the
availability of data on cyanide levels in apricot kernels is limited. In previous exposure assessments
performed by COT (2006) and FSANZ (2014), exposure assessments were therefore based on
numbers of kernels promoted to be consumed to obtain a ‘beneﬁcial’ health effect combined with ﬁxed
concentrations of cyanide in apricot kernels.
The COT considered a consumption of 5 kernels per hour with a maximum of 10 per day based on
information from a retailer. Based on information obtained from the Internet, consumption of 30 and
50 kernels per day was also considered. Combined with a mean cyanide concentration of 0.5 mg per
kernel (no information on individual kernels was available to COT), the acute exposure to cyanide was
estimated at 42 lg/kg bw per hour with a maximum of 83 lg/kg bw per day, and 250 and 417 lg/kg
bw per day, respectively (COT, 2006).
FSANZ (2014) estimated the exposure to cyanide via the consumption of four (previously
considered by FSANZ to be safe) and 32 kernels per day (promoted maximum intake provided on the
Internet) combined with a cyanide concentration of either 2,820 mg/kg in apricot kernels with skin or
440 mg/kg in apricot kernels without skin. These concentrations were the upper levels of a range of
concentrations analysed by FSANZ in 18 samples of apricot kernels with skin and 11 samples without
skin. One kernel was assumed to weigh 0.6 g. The resulting acute exposure estimates related to the
19 Mintel Global New Products Database (http://www.mintel.com/global-new-products-database). Accessed: 29 September 2015.
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consumption of 4 kernels per day equalled 91 (based on average body weight of 74 kg in persons
aged 17 and above in Australia) or 94 lg/kg bw per day (based on average body weight of 71 kg in
persons aged 15 and above in New Zealand) for apricot kernels with skin and 14 or 15 lg/kg bw per
day for those without skin, respectively. Corresponding acute exposure estimates for 32 kernels per
day were 724 or 755 and 113 or 118 lg/kg bw per day, respectively.
3.5.2. Current exposure assessment
The dietary exposure to cyanide via the consumption of raw apricot kernels was estimated
separately for toddlers and adults using the highest promoted portion size of 10 kernels per day for
the general population and of 60 apricot kernels per day for cancer patients (see Section 2.2.3).
Because very few data were available, two different scenarios were calculated based on the lower and
upper mean cyanide concentration levels in bitter apricot kernels reported in the literature, in order to give
an indication of the possible range of exposure (see Section 2.2.3). Mean values were considered
appropriate for both scenarios, as the cyanide content of individual kernels varies and if a large number of
kernels are consumed, not all will contain cyanide at the maximum reported level. The data for apricot
kernels described as sweet were too uncertain for use in exposure calculations because the concentrations
ranged from undetected up to within the range reported for apricot kernels described as bitter.
In the ﬁrst scenario, the concentration of cyanide was equal to 0.8 mg/g kernel while in the second
scenario the concentration of cyanide was equal to 3.3 mg/g kernel (Table 3).
Kernels were assumed to have an average weight of 0.5 g in both scenarios, based on the
midpoint of the range of reported mean kernel weight as presented in Table 2.
The results from the two exposure scenarios, in toddlers and in adults, separately for the general
population and cancer patients, are reported in Table 3.
3.6. Risk characterisation
3.6.1. Risk characterisation based on the consumption of 10 and 60 kernels per day
Due to the limited available data on concentrations of cyanide in apricot kernels and consumption
thereof, the CONTAM Panel considered the possible cyanide exposure that might arise from consumption
of the numbers of kernels promoted as healthy for the general population and for cancer patients,
together with the reported range of cyanide content of bitter apricot kernels, which also encompasses
the cyanide content of some apricots described as sweet. These estimated ranges exceed the ARfD of
20 lg/kg bw for both the general population and cancer patients in toddlers and in adults.
For toddlers, consumption of 10 kernels per day could lead to an exposure 17–69 times higher than
the ARfD, and consumption of 60 kernels per day could lead to an exposure 100–413 times higher
than the ARfD. For adults, consumption of 10 apricot kernels per day could result in an exposure from
3 to 12 times higher than the ARfD, while if 60 kernels per day are consumed, the exposure could be
17–71 times higher than the ARfD. Such exceedances are likely to result in cyanide toxicity in some
individuals, as is evident from the case reports of human poisoning. The potential exceedance by other
age groups would be between those for toddlers and adults.
Table 3: Estimated acute exposure to cyanide (lg/kg bw) for toddlers (12 kg bw) and adults
(70 kg bw) via the consumption of raw apricot kernels, assuming that apricot kernel
weight was equal to 0.5 g
Age group
Acute exposure to cyanide (lg/kg bw)
General population (10 kernels
per day)(a)
Cancer patients (60 kernels per day)(b)
First exposure
scenario
(lg/kg bw)
Second exposure
scenario
(lg/kg bw)
First exposure
scenario
(lg/kg bw)
Second exposure
scenario
(lg/kg bw)
Toddlers (1–3 years) 333 1,375 2,000 8,250
Adults (18–64 years) 57 236 343 1,414
bw: body weight.
(a): Highest daily portion size of raw apricot kernels promoted for general (healthy) population.
(b): Highest daily portion size of raw apricot kernels promoted for cancer patients.
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3.6.2. Estimation of an amount of apricot kernels that could be consumed
without exceeding the ARfD
In order to provide information that might be useful for risk managers, the Panel performed an
‘exposure back-calculation’ estimating the maximum quantity of apricot kernels (expressed as both
grams and number of kernels/day) that can be ingested without exceeding the ARfD of 20 lg/kg bw
for toddlers and adults. This calculation was performed using the highest concentration value of
cyanide in apricot kernels reported in the literature which is equal to 3.8 mg/g (see Section 3.3), a
value that is relevant to the consumption of a single kernel. Extrapolation to number of kernels is
based upon the range of individual kernel weights (0.12–0.84 g) reported by Abraham et al. (2016).
As shown in Table 4, the estimated maximum amount of apricot kernels that can be consumed by a
toddler is 0.06 g, while an adult could consume up to 0.37 g of kernel per day without exceeding the
ARfD, provided the cyanide content in the kernels does not exceed 3.8 mg/g. It is not possible for
consumers to measure such small amounts in the home. For a toddler, the ARfD would be exceeded
by the consumption of less than one kernel. For adults, three very small kernels could be consumed
without exceeding the ARfD, but consumption of less than one half of one large kernel could also
exceed the ARfD.
The CONTAM Panel noted that due to the lack of cyanide occurrence data in products derived from
raw apricot kernels, the maximum amount of raw apricot kernels that can be consumed without
exceeding the ARfD expressed as g kernels/day should be also applied to products derived from raw
apricot kernels. This includes ground apricot kernels, which could potentially release the maximum
amount of cyanide when freshly ground although over time the cyanide content could decrease due to
volatilisation, but there are no data to make a distinction between whole and ground kernels.
Moreover, no distinction could be made between bitter and sweet apricot kernels, or between apricot
kernels with and without skin due to the lack of adequate data.
3.7. Uncertainties
The evaluation of the inherent uncertainties in the assessment of the acute health risks related to
the presence of CNGs in raw apricot kernels and products derived from raw apricot kernels was
performed following the guidance of the opinion of the Scientiﬁc Committee related to Uncertainties in
Dietary Exposure Assessment (EFSA, 2006). In addition, the report ‘Characterizing and Communicating
Uncertainty in Exposure Assessment’ was considered (WHO/IPCS, 2008).
3.7.1. Assessment objectives
The objectives of the assessment are clariﬁed in Section 1.2.
3.7.2. Occurrence data/exposure assessment
No occurrence data on amygdalin or cyanide (originating from amygdalin) in raw apricot kernels
were available in the EFSA occurrence database. From the published literature, only very limited
occurrence data on amygdalin or cyanide in apricot kernels or products were available, which were
also very variable (Table 2). To address this uncertainty, two exposure scenarios were deﬁned to
Table 4: Estimated maximum amount and number of raw apricot kernels (g/day) that can be
consumed by toddlers and adults without exceeding the ARfD of 20 lg/kg bw
Age group
Body
weight (kg)
Cyanide
concentration
(mg/g)
Maximum amount of apricot
kernels (g kernels/day) that
can be consumed without
exceeding the ARfD
Number of apricot kernels
that can be consumed
without exceeding the
ARfD(a)
Toddlers
(1–3 years)
12 3.8 0.06 0.1–0.5
Adults
(18–64 years)
70 0.37 0.4–3.1
ARfD: acute reference dose.
(a): Assuming a kernel weight of 0.84 g is at the lower end of the range and of 0.12 g at the upper end of the range.
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assess the exposure to cyanide using either a lower or upper mean concentration as reported in the
literature (Section 3.3). For the estimation of the maximum weight of kernels that can be consumed
without exceeding the ARfD (Section 3.6.2), the highest reported concentration of cyanide in apricot
kernels was used (Table 2). Due to the limited data available, it is not unlikely that actual cyanide
levels in apricot kernels may be higher than the value used in this opinion. Due to this, the maximum
weight of kernels that can be consumed safely may in practice be lower than the weight estimated
here, which may have resulted in an underestimation of the risk.
In the EFSA database, also no consumption data on raw apricot kernels and products derived
thereof were available. Therefore, the CONTAM Panel used the consumption amounts cited on the
Internet to carry out exposure assessments for the general population and cancer patients. The extent
to which consumers follow the Internet recommendations is unknown.
There was also only very limited information available about the effects of processing on
amygdalin/cyanide content of apricot kernels. Therefore, the exposure assessment was based on data
for whole kernels, which is likely to overestimate exposure from products prepared from apricot
kernels.
The publicly available information did not provide objective criteria to discriminate between
amygdalin/cyanide concentrations in sweet and bitter apricot kernels. In addition, amygdalin/cyanide
contents in kernels reported as ‘bitter’ or ‘sweet’ overlapped. The lowest and highest mean values
reported in kernels described as bitter were used for the assessment in order to give an indication of
the possible exposure when consuming a large quantity of kernel. There is considerable uncertainty
about possible concentrations outside this range.
The weight of individual apricot kernels varies considerably. For the exposure assessment, the
midpoint of the published information on kernel weights was used, which might not reﬂect the actual
weights of kernels consumed. In reality, the actual kernel weight can be either lower or higher. The
estimated exposures to cyanide based on number of kernels consumed (10 and 60) could therefore
have been overestimated or underestimated, respectively.
In estimating the maximum number/weight of kernels that could be assumed without exceeding
the ARfD, the range of individual kernel weights in one batch of kernels was used in order to reﬂect
the uncertainty. However, it is possible that other kernels would be outside this weight range.
Furthermore, the maximum reported occurrence value of amygdalin cyanide was used. Because of the
very limited amount of data available, this maximum reported value could be lower than actually
occurs on the market. Therefore, the maximum weight of kernels that can be consumed without
exceeding the ARfD could be overestimated but not underestimated.
3.7.3. Other uncertainties
The assumption that a blood cyanide concentration of 20 lM is the threshold for toxicity in humans
was used as a basis for deriving the ARfD, although the original data underlying this assumption were
not available. This value of 20 lM would be an underestimate if, as is likely, the measurements were
made some time after peak blood cyanide concentrations would have occurred. However, there is no
information on whether a back-calculation was made to allow for the rapid elimination of cyanide, nor
of the number of individuals that the value is based on, and whether it covers potentially sensitive
subgroups.
The mean data from ﬁve females in a study indicating 100% bioavailability were used to
extrapolate the blood cyanide concentration of 20 lM to an external dose of total cyanide. Because
the effects of cyanide are due to peak blood concentrations, which occur rapidly after ingestion of
bitter apricot kernels, interindividual differences due to toxicokinetic variability are likely to be smaller
than the default value of 3.16 applied for differences in absorption, distribution, metabolism and
elimination. The variations in peak blood levels seen in the study from Abraham et al. (2016) were
small. Women have a smaller distribution volume of blood than men and children have a larger blood
volume (per kg/bw) as than adults. Therefore, a factor of 1.5 was considered sufﬁcient to cover any
additional variability in toxicokinetics. This could be an underestimation or overestimation of actual
variability.
The uncertainty with respect to extrapolation to more sensitive individuals was addressed by
applying the default UF of 3.16 for individual variation in toxicodynamics. The Panel noted that this
factor might not be fully required as the mode of action of cyanide, involving disruption of cellular
energy metabolism, does not indicate major individual variation in sensitivity.
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3.7.4. Summary of uncertainties
In Table 5, a summary of the uncertainty evaluation is presented, highlighting the main sources of
uncertainty and indicating an estimate of whether the source of uncertainty leads to overestimation/
underestimation of the resulting risk.
The overall uncertainty incurred with the present assessment is considered as high. The
assessment is more likely to overestimate than to underestimate the risk.
4. Conclusions
4.1. General
• Amygdalin is the major cyanogenic glycoside (CNG) present in apricot kernels.
• In intact apricot kernel cells, amygdalin and catabolic enzymes are stored in separate
compartments but can be brought into contact by physical processes such as grinding or by
chewing, thereby releasing cyanide.
• Complete degradation of 1 g of amygdalin releases 59 mg of hydrocyanic acid (hydrogen
cyanide, HCN). HCN is a weak acid and always exists as a mixture of non-dissociated acid and
its dissociated form (cyanide ions, CN) in aqueous environment. This mixture is referred to in
this opinion as ‘cyanide’.
• No validated methods are available for the measurement of amygdalin as well as cyanide
(originating from amygdalin) in raw apricot kernels or products derived thereof.
4.2. Hazard assessment
4.2.1. Toxicokinetics
• The absorption of intact amygdalin is minimal.
• Cyanide is released from amygdalin in apricot kernels during chewing and in the intestinal tract
by the gut microbiota.
• Cyanide is readily absorbed from the intestine, reaching maximum blood levels usually within
minutes.
• Cyanide in blood is mostly found in erythrocytes bound to methaemoglobin.
Table 5: Summary of uncertainties in the risk assessment of CNGs in raw apricot kernels and
products thereof
Sources of uncertainty Direction(a)
No occurrence data in the EFSA database and consequent need to rely on limited occurrence
data published in the literature
+/
Assumption of complete conversion of amygdalin to cyanide +
Limited data on the impact of food processing +
No objective criteria for discriminating between ‘sweet’ and ‘bitter’ apricot kernels +
Lack of consumption data +/
Appropriateness of the midpoint of the reported mean kernel weights used in the exposure
assessment
+/
Appropriateness of the range of the mean cyanide concentrations in the exposure assessment +/
Assumption that 20 lM cyanide in blood is a threshold for toxicity in humans, including sensitive
subgroups
+/
Selection of an uncertainty subfactor of 1.5 for toxicokinetic variability +/
Application of the default uncertainty subfactor of 3.16 for toxicodynamic variability +
Estimation of the maximum weight of kernels that can be consumed without exceeding the
ARfD using the maximum reported occurrence value which might be lower than actual maximum
values

ARfD: acute reference dose.
(a): +: uncertainty with potential to cause overestimation of exposure/risk; : uncertainty with potential to cause
underestimation of exposure/risk. Extent of potential overestimation/underestimation might differ in direction.
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• Cyanide has an initial half-life of about 1 h in blood and is rapidly distributed to all organs. The
volume of distribution has been estimated as 0.075 L/kg in humans.
• Thiocyanate is the major metabolite of cyanide, formed primarily in the liver and excreted in
the urine.
• The formation of thiocyanate represents a detoxiﬁcation of cyanide and depends on the
activity of certain enzymes and the availability of sulfur-containing amino acids.
• There are no pronounced species differences in cyanide toxicokinetics.
• Cyanide in blood has been frequently used as an exposure biomarker for cyanide poisoning. All
steps of storage, sample preparation and the analytic process itself have to be carried out with
caution to minimise the risk of cyanide loss and falsely low levels.
4.2.2. Acute and short-term toxicity in animal studies
• The overt clinical effects in experimental animals due to lethal levels of cyanide exposure are:
dyspnoea, irregular shallow and gasping breathing, ataxia, tremors, retrocolic spasms, tonic
spasms, loss of consciousness, convulsions and asphyxiation. Brain seems to be the organ
most sensitive to acute cyanide toxicity.
• Acute medium lethal oral doses (LD50) values for cyanides range from 2.13 to 6 mg/kg body
weight (bw).
• Upon short-term dietary exposure to cyanide, histopathological changes and organ weight
(e.g. decreased weights of cauda epididymis and thymus, and increased weights of liver) are
the parameters most frequently affected in adult rodents.
• A no observed adverse effect level (NOAEL) of 0.36 mg CN/kg bw and a lowest observed
acute effect level (LOAEL) of 1.2 mg CN/kg bw were established from a study in rats exposed
to KCN for 15 days, supported by the data from a study in rats dosed with NaCN for
13 weeks.
• Experimental data on amygdalin acute and short-term toxicity are too few to derive any
NOAEL and/or LOAEL.
• Indications of teratogenicity in offspring of hamsters treated with amygdalin on day 8 of
gestation were observed in one study while signs of toxicity were revealed both in rat dams
and their weanling offspring after exposure to KCN. In both studies, the cyanide doses were
higher than the NOAEL/LOAEL cited above.
4.2.3. Human observations
• The human acute lethal oral dose of HCN is reported to be 0.5–3.5 mg/kg bw. It is frequently
cited that the toxicity threshold for cyanide in whole blood is 0.5 mg/L (approximately 20 micro
mol, lM).
• Cases of acute cyanide toxicity have resulted from ingestion of amygdalin preparations and of
bitter apricot kernels, and some of these cases were fatal. For adults, the number of kernels
consumed was 20 or more. For children, ﬁve or more kernels appear to be toxic.
• In a study in a small number of healthy adults, there were no symptoms of cyanide toxicity at
cyanide equivalent doses of up to 0.113 mg/kg bw in women and 0.34 mg/kg bw in men (the
highest doses tested).
4.2.4. Mode of action for acute toxicity
• The primary mode of action underlying the acute toxicity of cyanide involves inhibition of
oxidative phosphorylation, in particular, by inhibiting cytochrome oxidase a3.
• Heart and brain are particularly prone to cyanide toxicity because they require continuous
supply of adenosine triphosphate generated by oxidative phosphorylation.
• Cyanide also inhibits several other enzymes and may act via a number of additional
mechanisms that contribute to its acute toxicity.
4.2.5. Acute reference dose
• The EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) concluded that an acute
reference dose (ARfD) should be established for cyanide in order to consider the acute health
risks related to CNGs in apricot kernels.
• The animal data did not provide a suitable basis for deriving an ARfD.
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• The CONTAM Panel concluded that the blood cyanide concentration of 20 lM, which is
reported to be a threshold for toxicity, should be used as the basis for deriving the ARfD,
extrapolating to an external dose of cyanide.
• In a bioavailability study, a group of 12 healthy adult volunteers consumed CNGs
corresponding to 6.8 mg cyanide from a number of different sources including bitter apricot
kernels. A cyanide exposure of 0.105 mg/kg bw was estimated to result in a mean peak blood
level of 20 lM in the females in the study.
• The CONTAM Panel concluded that the dose of 0.105 mg/kg bw resulting in a blood
concentration of about 20 lM in the females should be used as the basis for deriving the ARfD.
• Assuming that CNGs are completely broken down to cyanide, and that the cyanide is rapidly
absorbed and 100% bioavailable, it is highly unlikely that individual variability could lead to
appreciably higher peak blood levels. Because of the very short time to peak blood level,
individual differences in metabolism (e.g. due to reduced activity of rhodanese) could delay
elimination, but are unlikely to have an impact on the peak level. The variations in peak blood
levels seen in the study from Abraham et al. (2016) were small. Women have a smaller
distribution volume of blood than men and children have a larger blood volume (per kg/bw)
than adults. Therefore, the CONTAM Panel concluded that a default factor of 3.16 was not
required and that a factor of 1.5 was sufﬁcient to cover any additional variability in
toxicokinetics.
• In considering a need for a toxicodynamics subfactor, the CONTAM Panel noted the lack of
information on whether potentially sensitive individuals (e.g. children) were included in the
database underpinning the assumption that a blood cyanide level of 20 lM is a toxicity
threshold, and that the bioavailability study was conducted in a small number of healthy
volunteers. The CONTAM Panel concluded that a toxicodynamic subfactor should be applied,
and in the absence of cyanide-speciﬁc data on individual sensitivity, adopted the default
subfactor of 3.16.
• Dividing the NOAEL of 0.105 mg/kg bw by the factors of 1.5 and 3.16, with rounding to a single
signiﬁcant ﬁgure, an ARfD for cyanide of 0.02 mg/kg bw (20 lg/kg bw) is established for use in
assessing the risks associated with the presence of CNGs in apricot kernels.
4.3. Exposure assessment
• There is substantial variation in cyanide content within kernels described both as ‘sweet’ and
‘bitter’. However, there appears to be no objective criteria to discriminate between sweet and
bitter kernels and the cyanide content in these groups overlaps.
• In the absence of consumption data, the highest number of kernels promoted for the general
population and cancer patients (10 and 60 kernels, respectively) by apricot kernel vendors
were used for exposure assessment together with the highest and lowest mean values for
cyanide concentrations in apricot kernels described as ‘bitter’.
• For the general population, resulting exposures were 333 and 57 lg/kg bw assuming low
cyanide content and 1,375 and 236 lg/kg bw assuming high cyanide content, for toddlers and
adults, respectively. For cancer patients, the corresponding numbers were 2,000 and 343 lg/kg
bw and 8,250 and 1,414 lg/kg bw.
• Given the lack of consumption data and the very limited information on cyanide in apricot
kernels, the exposure estimates of cyanide reported in this opinion are highly uncertain. The
real exposure in a speciﬁc consumer may be either higher or lower, but, given the
uncertainties, it is estimated that the real exposure is more likely to be lower than higher than
the intakes reported here.
4.4. Risk characterisation
• If consumers follow the recommendations of websites that promote consumption of apricot
kernels, their exposure to cyanide will greatly exceed the ARfD. Such exceedances are likely to
result in cyanide toxicity in some individuals, as is evident from the case reports of human
poisoning.
• The estimated maximum quantity of apricot kernels that could be eaten by a toddler is 0.06 g,
while an adult could eat up to 0.37 g of kernel per day without exceeding the ARfD. It is not
possible for consumers to measure such small quantities in the home.
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• For a toddler, the ARfD would be exceeded by the consumption of less than one kernel. For
adults, very small kernels could be consumed without exceeding the ARfD, but consumption of
one large kernel could also exceed the ARfD.
• The CONTAM Panel was not able to separately characterise risks associated with sweet raw
apricot kernels, products containing raw apricot kernels or processed raw apricot kernels (e.g.
ground, without skin, etc.) due to the lack of adequate data.
5. Recommendations
• Information is needed on whether there is an objective distinction between ‘sweet’ and ‘bitter’
apricot kernels, and if so whether the cyanide contents differ.
• Data are needed on the occurrence of cyanide in whole raw apricot kernels and products
derived from them.
• More information is required on the impact of removing the skin and other forms of processing
on the cyanide content.
• Data are required on consumption of products prepared from raw apricot kernels.
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Abbreviations
a-KG a-ketoglutarate
a-KGCN a-ketoglutarate cyanohydrin
ADP adenosine diphosphate
AFC Panel EFSA Panel on Food Additives, Flavourings, Processing Aids and
Materials in Contact with Food
AH amygdalin hydrolase
ALT alanine aminotransferase
ARfD acute reference dose
ATCA 2-amino-2-thiazoline-4-carboxylic acid
ATP adenosine triphosphate
ATSDR Agency for Toxic Substances and Disease Registry
BfR German Federal Institute for Risk Assessment
bw body weight
BMD Benchmark dose
BMDL10 95% lower conﬁdence limit for the benchmark dose response of 10% extra risk
CAS Chemical Abstracts Service
CONTAM Panel EFSA Panel on Contaminants in the Food Chain
CNG cyanogenic glycoside
COT UK Committee on Toxicity of Chemicals in Food, Consumer
Products and the Environment
CYP cytochrome P450
DECOS Dutch Expert Committee on Occupational Standards
EC European Commission, Enzyme commission number
EFET The Hellenic Food Authority
ELISA enzyme-linked immunosorbent assay
FAO/WHO Food and Agriculture Organization of the United Nations/World
Health Organization
FSANZ Food Standards Australia New Zealand
GC gas chromatography
GC-MS gas chromatography mass spectrometry
GD gestation day
GC-ECD gas chromatography-electronic capture detection
GC-MPD gas chromatography-microwave-induced plasma atomic emission detection
HCN hydrocyanic acid
HPLC high performance liquid chromatography
HPLC-DAD high performance liquid chromatography with diode-array detection
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HPLC-MS/MS high performance liquid chromatography-tandem mass spectrometry
HPLC-UV high performance liquid chromatography with UV detection
i.v. intravenous
IPCS International Programme on Chemical Safety
JECFA Joint FAO/WHO Expert Committee on Food Additives
KCN potassium cyanide
LC liquid chromatography
LC-MS/MS liquid chromatography-tandem mass spectrometry
LD50 median lethal dose
LOAEL lowest observed adverse effect level
LOD limit of detection
MNL mandelonitrile lyase
MPST mercaptopyruvate sulfurtransferase
NADH nicotinamide adenine dinucleotide
NOAEL no observed adverse effect level
NTP National Toxicology Program
PH prunasin hydrolase
PMTDI Provisional Maximum Tolerable Daily Intake
PND postnatal day
SD standard deviation
TSH thyroid stimulating hormone
UF uncertainty factor
UGT uridine diphosphate glucose-glucosyl transferase
US EPA US Environmental Protection Agency
UV ultraviolet
VDL-UFA Association of German Agricultural Analytic and Research Institutes
WHO World Health Organization
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Appendix A – Identiﬁcation and selection of relevant scientiﬁc literature
and reports
Table A.1: Search terms and information source for literature search on cyanide
Chemistry and analysis
Search terms TOPIC: (‘hydrocyanic acid’ OR ‘cyanogenic glycosides’
OR amygdalin OR prunasin OR prussic acid OR laetrile
OR formonitrile OR ‘Vitamin B17’)
TOPIC: (bitter apricot OR
apricot paste)
AND TOPIC: (chemistry OR analysis OR determination OR detection OR identiﬁcation
OR formation OR GC OR GC-MS OR HPLC OR LC-MS OR ICP-MS)
Information
source
Number of records retrieved
Web of Science 885 30
PubMed 221 30
Formation, Occurrence, Exposure
Search terms TOPIC: (‘hydrocyanic acid’ OR ‘cyanogenic glycosides’
OR amygdalin OR prunasin OR prussic acid OR laetrile
OR formonitrile OR ‘Vitamin B17’)
TOPIC: (bitter apricot OR
apricot paste)
AND TOPIC: (occurrence OR exposure OR assessment OR levels OR concentrate*
OR raw apricot kernels)
Information
source
Number of records retrieved
Web of Science 628 143
PubMed 80 7
Metabolism, Kinetics
Search terms TOPIC: (‘hydrocyanic acid’ OR ‘cyanogenic glycosides’
OR amygdalin OR prunasin OR prussic acid OR laetrile
OR formonitrile OR ‘Vitamin B17’)
TOPIC: (bitter apricot
OR apricot paste)
AND TOPIC: (toxicokinetic* OR metabolism OR distribution OR excretion OR absorption OR
distribution OR biomarker OR mode of action OR biotransformation OR elimination
OR reduction OR detoxiﬁcation OR extraction)
Information
source
Number of records retrieved
Web of Science 605 166
PubMed 221 25
Food processing
Search terms TOPIC: (‘hydrocyanic acid’ OR ‘cyanogenic glycosides’
OR amygdalin OR prunasin OR prussic acid OR laetrile
OR formonitrile OR ‘Vitamin B17’)
TOPIC: (bitter apricot OR
apricot paste)
AND TOPIC: (ground OR powder OR milled OR ﬂour OR cracked OR chopped OR
hulled OR unhulled OR ‘with skin’ OR ‘without skin’)
Information
source
Number of records retrieved
Web of Science 175 53
PubMed 18 4
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Chemistry and analysis
Toxicity
Search terms TOPIC: (‘hydrocyanic acid’ OR ‘cyanogenic glycosides’
OR amygdalin OR prunasin OR prussic acid OR laetrile
OR formonitrile OR ‘Vitamin B17’)
TOPIC: (bitter apricot
OR apricot paste)
AND TOPIC: (toxicity OR toxi* OR acute OR subacute OR subchronic OR chronic OR
mutagen*
OR carcino* OR genotox* OR reprotox* OR nephrotox* OR neurotox* OR hepatotox* OR
immunotox* OR haemotox* OR hematotox* OR cytotox* OR develop* toxicity OR thyroid
OR endocri* OR poisoning OR incidental poisoning OR rat OR mouse OR lab animal OR
animal*
OR case studies)
Information
source
Number of records retrieved
Web of Science 899 205
PubMed 135 15
Epidemiology
Search terms TOPIC: (‘hydrocyanic acid’ OR ‘cyanogenic glycosides’
OR amygdalin OR prunasin OR prussic acid OR laetrile
OR formonitrile OR ‘Vitamin B17’)
TOPIC: (bitter apricot OR apricot
paste)
AND TOPIC: (biomarker OR biological marker OR case studies OR incidental poisoning
OR poisoning OR human poisoning)
Information
source
Number of records retrieved
Web of Science 209 48
PubMed 41 5
Date accessed 4 June 2015 4 September 2015
Total number
retrieved
4,117 731
Number after
duplicate
removal
1,733 401
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Appendix B – EFSA guidance documents used for the assessment
• EFSA (European Food Safety Authority), 2010. Management of left-censored data in dietary
exposure assessment of chemical substances. EFSA Journal 2010;8(3):1557, 96 pp.
doi:10.2903/j.efsa.2010.1557
• EFSA (European Food Safety Authority), 2011. Overview of the procedures currently used at
EFSA for the assessment of dietary exposure to different chemical substances. EFSA Journal
2011;9(12):2490, 33 pp. doi:10.2903/j.efsa.2011.2490
• EFSA (European Food Safety Authority), 2011. Use of BMDS and PROAST software packages
by EFSA Scientiﬁc Panels and Units for applying the Benchmark Dose (BMD) approach risk
assessment. Technical Report. EN-113. 190 pp.
• EFSA Scientiﬁc Committee, 2006. Guidance of the Scientiﬁc Committee on a request from EFSA
related to uncertainties in Dietary Exposure Assessment. EFSA Journal 2007;4(1):438, 54 pp.
doi:10.2903/j.efsa.2007.438
• EFSA Scientiﬁc Committee, 2009. Guidance of the Scientiﬁc Committee on transparency in the
scientiﬁc aspects of risk assessments carried out by EFSA. Part 2: General principles. EFSA
Journal 2009;6(5):1051, 22 pp. doi:10.2903/j.efsa.2009.1051
• EFSA Scientiﬁc Committee, 2009. Guidance of the Scientiﬁc Committee on use of the
benchmark dose approach in risk assessment. EFSA Journal 2009;6(6):1150, 72 pp.
doi:10.2903/j.efsa.2009.1150
• EFSA Scientiﬁc Committee, 2012. Guidance on selected default values to be used by the EFSA
Scientiﬁc Committee, Scientiﬁc Panels and Units in the absence of actual measured data. EFSA
Journal 2012;10(3):2579, 32 pp. doi:10.2903/j.efsa.2012.2579
• EFSA Scientiﬁc Committee, 2012. Scientiﬁc Opinion on Risk Assessment Terminology. EFSA
Journal 2012;10(5):2664, 43 pp. doi:10.2903/j.efsa.2012.2664
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